Search

Your search keyword '"Sebastian Kliwicki"' showing total 24 results
Start Over Author "Sebastian Kliwicki"
24 results on '"Sebastian Kliwicki"'

1. Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder

Author

Céline S. Reinbold, Andreas J. Forstner, Julian Hecker, Janice M. Fullerton, Per Hoffmann, Liping Hou, Urs Heilbronner, Franziska Degenhardt, Mazda Adli, Kazufumi Akiyama, Nirmala Akula, Raffaella Ardau, Bárbara Arias, Lena Backlund, Antonio Benabarre, Susanne Bengesser, Abesh K. Bhattacharjee, Joanna M. Biernacka, Armin Birner, Cynthia Marie-Claire, Pablo Cervantes, Guo-Bo Chen, Hsi-Chung Chen, Caterina Chillotti, Scott R. Clark, Francesc Colom, David A. Cousins, Cristiana Cruceanu, Piotr M. Czerski, Alexandre Dayer, Bruno Étain, Peter Falkai, Louise Frisén, Sébastien Gard, Julie S. Garnham, Fernando S. Goes, Paul Grof, Oliver Gruber, Ryota Hashimoto, Joanna Hauser, Stefan Herms, Stéphane Jamain, Esther Jiménez, Jean-Pierre Kahn, Layla Kassem, Sarah Kittel-Schneider, Sebastian Kliwicki, Barbara König, Ichiro Kusumi, Nina Lackner, Gonzalo Laje, Mikael Landén, Catharina Lavebratt, Marion Leboyer, Susan G. Leckband, Carlos A. López Jaramillo, Glenda MacQueen, Mirko Manchia, Lina Martinsson, Manuel Mattheisen, Michael J. McCarthy, Susan L. McElroy, Marina Mitjans, Francis M. Mondimore, Palmiero Monteleone, Caroline M. Nievergelt, Urban Ösby, Norio Ozaki, Roy H. Perlis, Andrea Pfennig, Daniela Reich-Erkelenz, Guy A. Rouleau, Peter R. Schofield, K. Oliver Schubert, Barbara W. Schweizer, Florian Seemüller, Giovanni Severino, Tatyana Shekhtman, Paul D. Shilling, Kazutaka Shimoda, Christian Simhandl, Claire M. Slaney, Jordan W. Smoller, Alessio Squassina, Thomas J. Stamm, Pavla Stopkova, Sarah K. Tighe, Alfonso Tortorella, Gustavo Turecki, Julia Volkert, Stephanie H. Witt, Adam J. Wright, L. Trevor Young, Peter P. Zandi, James B. Potash, J. Raymond DePaulo, Michael Bauer, Eva Reininghaus, Tomáš Novák, Jean-Michel Aubry, Mario Maj, Bernhard T. Baune, Philip B. Mitchell, Eduard Vieta, Mark A. Frye, Janusz K. Rybakowski, Po-Hsiu Kuo, Tadafumi Kato, Maria Grigoroiu-Serbanescu, Andreas Reif, Maria Del Zompo, Frank Bellivier, Martin Schalling, Naomi R. Wray, John R. Kelsoe, Martin Alda, Francis J. McMahon, Thomas G. Schulze, Marcella Rietschel, Markus M. Nöthen, and Sven Cichon

Subjects
bipolar disorder, lithium response, microRNA, common variants, genome-wide association study, Psychiatry, RC435-571
Abstract

Bipolar disorder (BD) is a common, highly heritable neuropsychiatric disease characterized by recurrent episodes of mania and depression. Lithium is the best-established long-term treatment for BD, even though individual response is highly variable. Evidence suggests that some of this variability has a genetic basis. This is supported by the largest genome-wide association study (GWAS) of lithium response to date conducted by the International Consortium on Lithium Genetics (ConLiGen). Recently, we performed the first genome-wide analysis of the involvement of miRNAs in BD and identified nine BD-associated miRNAs. However, it is unknown whether these miRNAs are also associated with lithium response in BD. In the present study, we therefore tested whether common variants at these nine candidate miRNAs contribute to the variance in lithium response in BD. Furthermore, we systematically analyzed whether any other miRNA in the genome is implicated in the response to lithium. For this purpose, we performed gene-based tests for all known miRNA coding genes in the ConLiGen GWAS dataset (n = 2,563 patients) using a set-based testing approach adapted from the versatile gene-based test for GWAS (VEGAS2). In the candidate approach, miR-499a showed a nominally significant association with lithium response, providing some evidence for involvement in both development and treatment of BD. In the genome-wide miRNA analysis, 71 miRNAs showed nominally significant associations with the dichotomous phenotype and 106 with the continuous trait for treatment response. A total of 15 miRNAs revealed nominal significance in both phenotypes with miR-633 showing the strongest association with the continuous trait (p = 9.80E-04) and miR-607 with the dichotomous phenotype (p = 5.79E-04). No association between miRNAs and treatment response to lithium in BD in either of the tested conditions withstood multiple testing correction. Given the limited power of our study, the investigation of miRNAs in larger GWAS samples of BD and lithium response is warranted.

Published
2018
Full Text
View/download PDF

2. Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report.

Author

Mirko Manchia, Mazda Adli, Nirmala Akula, Raffaella Ardau, Jean-Michel Aubry, Lena Backlund, Claudio Em Banzato, Bernhard T Baune, Frank Bellivier, Susanne Bengesser, Joanna M Biernacka, Clara Brichant-Petitjean, Elise Bui, Cynthia V Calkin, Andrew Tai Ann Cheng, Caterina Chillotti, Sven Cichon, Scott Clark, Piotr M Czerski, Clarissa Dantas, Maria Del Zompo, J Raymond Depaulo, Sevilla D Detera-Wadleigh, Bruno Etain, Peter Falkai, Louise Frisén, Mark A Frye, Jan Fullerton, Sébastien Gard, Julie Garnham, Fernando S Goes, Paul Grof, Oliver Gruber, Ryota Hashimoto, Joanna Hauser, Urs Heilbronner, Rebecca Hoban, Liping Hou, Stéphane Jamain, Jean-Pierre Kahn, Layla Kassem, Tadafumi Kato, John R Kelsoe, Sarah Kittel-Schneider, Sebastian Kliwicki, Po-Hsiu Kuo, Ichiro Kusumi, Gonzalo Laje, Catharina Lavebratt, Marion Leboyer, Susan G Leckband, Carlos A López Jaramillo, Mario Maj, Alain Malafosse, Lina Martinsson, Takuya Masui, Philip B Mitchell, Frank Mondimore, Palmiero Monteleone, Audrey Nallet, Maria Neuner, Tomás Novák, Claire O'Donovan, Urban Osby, Norio Ozaki, Roy H Perlis, Andrea Pfennig, James B Potash, Daniela Reich-Erkelenz, Andreas Reif, Eva Reininghaus, Sara Richardson, Guy A Rouleau, Janusz K Rybakowski, Martin Schalling, Peter R Schofield, Oliver K Schubert, Barbara Schweizer, Florian Seemüller, Maria Grigoroiu-Serbanescu, Giovanni Severino, Lisa R Seymour, Claire Slaney, Jordan W Smoller, Alessio Squassina, Thomas Stamm, Jo Steele, Pavla Stopkova, Sarah K Tighe, Alfonso Tortorella, Gustavo Turecki, Naomi R Wray, Adam Wright, Peter P Zandi, David Zilles, Michael Bauer, Marcella Rietschel, Francis J McMahon, Thomas G Schulze, and Martin Alda

Subjects
Medicine, Science
Abstract

The assessment of response to lithium maintenance treatment in bipolar disorder (BD) is complicated by variable length of treatment, unpredictable clinical course, and often inconsistent compliance. Prospective and retrospective methods of assessment of lithium response have been proposed in the literature. In this study we report the key phenotypic measures of the "Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder" scale currently used in the Consortium on Lithium Genetics (ConLiGen) study.Twenty-nine ConLiGen sites took part in a two-stage case-vignette rating procedure to examine inter-rater agreement [Kappa (κ)] and reliability [intra-class correlation coefficient (ICC)] of lithium response. Annotated first-round vignettes and rating guidelines were circulated to expert research clinicians for training purposes between the two stages. Further, we analyzed the distributional properties of the treatment response scores available for 1,308 patients using mixture modeling.Substantial and moderate agreement was shown across sites in the first and second sets of vignettes (κ = 0.66 and κ = 0.54, respectively), without significant improvement from training. However, definition of response using the A score as a quantitative trait and selecting cases with B criteria of 4 or less showed an improvement between the two stages (ICC1 = 0.71 and ICC2 = 0.75, respectively). Mixture modeling of score distribution indicated three subpopulations (full responders, partial responders, non responders).We identified two definitions of lithium response, one dichotomous and the other continuous, with moderate to substantial inter-rater agreement and reliability. Accurate phenotypic measurement of lithium response is crucial for the ongoing ConLiGen pharmacogenomic study.

Published
2013
Full Text
View/download PDF

3. Studies on candidate genes for lithium prophylaxis performed at the Poznan University of Medical Sciences

Author

Ewa Ferensztajn-Rochowiak, Monika Dmitrzak-Węglarz, Aleksandra Szczepankiewicz, Maria Skibińska, Sebastian Kliwicki, Agnieszka Permoda-Pachuta, Aleksandra Suwalska, Piotr Czerski, Joanna Pawlak, and Joanna Hauser

Subjects
Psychiatry and Mental health, General Medicine
Abstract

Lit jest lekiem normotymicznym, stosowanym z wyboru w leczeniu profilaktycznym choroby afektywnej dwubiegunowej (ChAD). Skuteczność profilaktyczna litu może być uwarukowana czynnikami genetycznymi, związanymi częściowo z predyspozycją do choroby afektywnej dwubiegunowej. W dziedzinie genetyki w psychiatrii pierwsza dekada XXI wieku została zdominowana przez badania „genów kandydujących”. W niniejszym artykule przedstawiono badania genów kandydujących związanych z profilaktyką litem, prowadzone na Uniwersytecie Medycznym w Poznaniu w latach 2005-2018. W tym czasie badane były polimorfizmy wielu genów, z których część jest również związana z predyspozycją do choroby afektywnej dwubiegunowej. Związek ze skutecznością profilaktyczną litu stwierdzono w przypadku polimorfizmów genów 5HTT, ACP1, ARNTL, BDNF, COMT, DRD1, FKBP5, FYN, GLCC, NR3C1 i TIM. Nie stwierdzono takiego związku w odniesieniu do genów 5HT2A, 5HT2C, DRD2, DRD3, DRD3, GRIN2B, GSK-3β, MMP-9 i NTRK2. Wykazano natomiast asocjację polimorfizmu genu GSK-3β z nerkowymi działaniami niepożądanymi w przebiegu stosowania litem. Omówiona została możliwa rola tych genów zarówno w mechanizmie profilaktycznej skuteczności litu, jak i w patogenezie choroby afektywnej dwubiegunowej.

Published
2022

4. Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach - CORRIGENDUM

Author

Micah, Cearns, Azmeraw T, Amare, Klaus Oliver, Schubert, Anbupalam, Thalamuthu, Joseph, Frank, Fabian, Streit, Mazda, Adli, Nirmala, Akula, Kazufumi, Akiyama, Raffaella, Ardau, Bárbara, Arias, JeanMichel, Aubry, Lena, Backlund, Abesh Kumar, Bhattacharjee, Frank, Bellivier, Antonio, Benabarre, Susanne, Bengesser, Joanna M, Biernacka, Armin, Birner, Clara, Brichant-Petitjean, Pablo, Cervantes, HsiChung, Chen, Caterina, Chillotti, Sven, Cichon, Cristiana, Cruceanu, Piotr M, Czerski, Nina, Dalkner, Alexandre, Dayer, Franziska, Degenhardt, Maria Del, Zompo, J Raymond, DePaulo, Bruno, Étain, Peter, Falkai, Andreas J, Forstner, Louise, Frisen, Mark A, Frye, Janice M, Fullerton, Sébastien, Gard, Julie S, Garnham, Fernando S, Goes, Maria, Grigoroiu-Serbanescu, Paul, Grof, Ryota, Hashimoto, Joanna, Hauser, Urs, Heilbronner, Stefan, Herms, Per, Hoffmann, Andrea, Hofmann, Liping, Hou, Yi-Hsiang, Hsu, Stephane, Jamain, Esther, Jiménez, Jean-Pierre, Kahn, Layla, Kassem, Po-Hsiu, Kuo, Tadafumi, Kato, John, Kelsoe, Sarah, Kittel-Schneider, Sebastian, Kliwicki, Barbara, König, Ichiro, Kusumi, Gonzalo, Laje, Mikael, Landén, Catharina, Lavebratt, Marion, Leboyer, Susan G, Leckband, Mario, Maj, Mirko, Manchia, Lina, Martinsson, Michael J, McCarthy, Susan, McElroy, Francesc, Colom, Marina, Mitjans, Francis M, Mondimore, Palmiero, Monteleone, Caroline M, Nievergelt, Markus M, Nöthen, Tomas, Novák, Claire, O'Donovan, Norio, Ozaki, Vincent, Millischer, Sergi, Papiol, Andrea, Pfennig, Claudia, Pisanu, James B, Potash, Andreas, Reif, Eva, Reininghaus, Guy A, Rouleau, Janusz K, Rybakowski, Martin, Schalling, Peter R, Schofield, Barbara W, Schweizer, Giovanni, Severino, Tatyana, Shekhtman, Paul D, Shilling, Katzutaka, Shimoda, Christian, Simhandl, Claire M, Slaney, Alessio, Squassina, Thomas, Stamm, Pavla, Stopkova, Fasil, TekolaAyele, Alfonso, Tortorella, Gustavo, Turecki, Julia, Veeh, Eduard, Vieta, Stephanie H, Witt, Gloria, Roberts, Peter P, Zandi, Martin, Alda, Michael, Bauer, Francis J, McMahon, Philip B, Mitchell, Thomas G, Schulze, Marcella, Rietschel, Scott R, Clark, and Bernhard T, Baune

Subjects
Machine Learning, Psychiatry and Mental health, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant, Bipolar Disorder, Humans, Lithium
Published
2022

5. Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study

Author

Francis M. Mondimore, Farah Klohn-Sagatholislam, Jana Strohmaier, Jens Wiltfang, Jay Raymond DePaulo, Udo Dannlowski, Markus Jäger, Moritz E. Wigand, Ion Anghelescu, Michael Bauer, Louise Frisén, Ashley L. Comes, Carsten Spitzer, Claire Slaney, Janice M. Fullerton, Giovanni Severino, Janusz K. Rybakowski, Andreas J. Fallgatter, Maria Hake, Martin Alda, Peter R. Schofield, Susanne Bengesser, Nirmala Akula, Stefan Herms, Paul D. Shilling, Franziska Degenhardt, Mazda Adli, Armin Birner, Alexandre Dayer, Cristiana Cruceanu, Fanny Senner, Peter Falkai, Maria Del Zompo, Mark A. Frye, Christian Simhandl, Stéphane Jamain, Andrea Pfennig, Layla Kassem, Sébastien Gard, Heike Anderson-Schmidt, Marion Leboyer, Peter P. Zandi, Susan L. McElroy, Martin Schalling, Sebastian Stierl, Detlef E. Dietrich, Frank Bellivier, Palmiero Monteleone, Sybille Schulz, Caterina Chillotti, Volker Arolt, Michael McCarthy, Alfonso Tortorella, Andreas Thiel, Marcella Rietschel, Kristina Adorjan, Tatyana Shekhtman, Maria Grigoroiu-Serbanescu, Jean-Michel Aubry, Daniela Reich-Erkelenz, Laura Flatau, Markus Reitt, Harald Scherk, Here Folkerts, Julia Veeh, Joanna Hauser, Fernando S. Goes, Philip B. Mitchell, Gustavo Turecki, John R. Kelsoe, Thomas Stamm, Sophia Stegmaier, Georg Juckel, Markus M. Nöthen, Lina Martinsson, Bárbara Arias, Vanessa Nieratschker, Clara Brichant-Petitjean, Antonio Benabarre, Bernhard T. Baune, James B. Potash, Urs Heilbronner, Caroline M. Nievergelt, Raffaella Ardau, Mikael Landén, Pablo Cervantes, Pavla Stopkova, Adam Wright, Tomas Novak, Scott R. Clark, Manfred Koller, Gonzalo Laje, Katrin Gade, Andreas J. Forstner, Sarah Kittel-Schneider, Susan G. Leckband, Sebastian Kliwicki, Guy A. Rouleau, Kim Bartholdi, Martin von Hagen, Per Hoffmann, Eva C. Schulte, Alessio Squassina, Monika Budde, Thomas G. Schulze, Eduard Vieta, Liping Hou, Jörg Zimmermann, Barbara König, Stephan Ripke, Sarah K. Tighe, Jean-Pierre Kahn, Julie Garnham, Piotr M. Czerski, Janos Kalman, Anna Gryaznova, Francis J. McMahon, Mario Maj, Thomas Becker, Thomas Ethofer, Andreas Reif, Carsten Konrad, Mirko Manchia, Lena Backlund, Jens Reimer, Urban Ösby, Esther Jiménez, Abesh Kumar Bhattacharjee, Marina Mitjans, Sergi Papiol, Stephanie H. Witt, Sven Cichon, Bruno Etain, Till F. M. Andlauer, Joanna M. Biernacka, Max Schmauß, Christian Figge, Fabian U. Lang, N. Lackner, Eva Z. Reininghaus, Francesc Colom, Catharina Lavebratt, K Oliver Schubert, Kalman, Janos L, Papiol, Sergi, Forstner, Andreas J, Heilbronner, Ur, Degenhardt, Franziska, Strohmaier, Jana, Adli, Mazda, Adorjan, Kristina, Akula, Nirmala, Alda, Martin, Anderson-Schmidt, Heike, Andlauer, Till Fm, Anghelescu, Ion-George, Ardau, Raffaella, Arias, Bárbara, Arolt, Volker, Aubry, Jean-Michel, Backlund, Lena, Bartholdi, Kim, Bauer, Michael, Baune, Bernhard T, Becker, Thoma, Bellivier, Frank, Benabarre, Antonio, Bengesser, Susanne, Bhattacharjee, Abesh Kumar, Biernacka, Joanna M, Birner, Armin, Brichant-Petitjean, Clara, Budde, Monika, Cervantes, Pablo, Chillotti, Caterina, Cichon, Sven, Clark, Scott R, Colom, Francesc, Comes, Ashley L, Cruceanu, Cristiana, Czerski, Piotr M, Dannlowski, Udo, Dayer, Alexandre, Del Zompo, Maria, Depaulo, Jay Raymond, Dietrich, Detlef E, Étain, Bruno, Ethofer, Thoma, Falkai, Peter, Fallgatter, Andrea, Figge, Christian, Flatau, Laura, Folkerts, Here, Frisen, Louise, Frye, Mark A, Fullerton, Janice M, Gade, Katrin, Gard, Sébastien, Garnham, Julie S, Goes, Fernando S, Grigoroiu-Serbanescu, Maria, Gryaznova, Anna, Hake, Maria, Hauser, Joanna, Herms, Stefan, Hoffmann, Per, Hou, Liping, Jäger, Marku, Jamain, Stephane, Jiménez, Esther, Juckel, Georg, Kahn, Jean-Pierre, Kassem, Layla, Kelsoe, John, Kittel-Schneider, Sarah, Kliwicki, Sebastian, Klohn-Sagatholislam, Farah, Koller, Manfred, König, Barbara, Konrad, Carsten, Lackner, Nina, Laje, Gonzalo, Landén, Mikael, Lang, Fabian U, Lavebratt, Catharina, Leboyer, Marion, Leckband, Susan G, Maj, Mario, Manchia, Mirko, Martinsson, Lina, Mccarthy, Michael J, Mcelroy, Susan L, Mcmahon, Francis J, Mitchell, Philip B, Mitjans, Marina, Mondimore, Francis M, Monteleone, Palmiero, Nieratschker, Vanessa, Nievergelt, Caroline M, Novák, Toma, Ösby, Urban, Pfennig, Andrea, Potash, James B, Reich-Erkelenz, Daniela, Reif, Andrea, Reimer, Jen, Reininghaus, Eva, Reitt, Marku, Ripke, Stephan, Rouleau, Guy A, Rybakowski, Janusz K, Schalling, Martin, Scherk, Harald, Schmauß, Max, Schofield, Peter R, Schubert, K Oliver, Schulte, Eva C, Schulz, Sybille, Senner, Fanny, Severino, Giovanni, Shekhtman, Tatyana, Shilling, Paul D, Simhandl, Christian, Slaney, Claire M, Spitzer, Carsten, Squassina, Alessio, Stamm, Thoma, Stegmaier, Sophia, Stierl, Sebastian, Stopkova, Pavla, Thiel, Andrea, Tighe, Sarah K, Tortorella, Alfonso, Turecki, Gustavo, Vieta, Eduard, Veeh, Julia, von Hagen, Martin, Wigand, Moritz E, Wiltfang, Jen, Witt, Stephanie, Wright, Adam, Zandi, Peter P, Zimmermann, Jörg, Nöthen, Marku, Rietschel, Marcella, and Schulze, Thomas G

Subjects
Adult, Male, Oncology, Multifactorial Inheritance, medicine.medical_specialty, Schizophrenia/genetics, Disease onset, Adolescent, early onset, Late onset, ddc:616.89, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Bipolar disorder, Child, Research Articles, Biological Psychiatry, bipolar disorder, Trastorn bipolar, business.industry, Bipolar Disorder/genetics, age at onset, polygenic risk score, schizophrenia, Age Factors, Bipolar Disorder, Female, Middle Aged, Phenotype, Schizophrenia, Original Articles, medicine.disease, Genetic architecture, 030227 psychiatry, Psychiatry and Mental health, Institutional repository, Clinical research, Esquizofrènia, Original Article, business, 030217 neurology & neurosurgery
Abstract

OBJECTIVES: Bipolar disorder (BD) with early disease onset is associated with an unfavorable clinical outcome and constitutes a clinically and biologically homogenous subgroup within the heterogeneous BD spectrum. Previous studies have found an accumulation of early age at onset (AAO) in BD families and have therefore hypothesized that there is a larger genetic contribution to the early-onset cases than to late onset BD. To investigate the genetic background of this subphenotype, we evaluated whether an increased polygenic burden of BD- and schizophrenia (SCZ)-associated risk variants is associated with an earlier AAO in BD patients. METHODS: A total of 1995 BD type 1 patients from the Consortium of Lithium Genetics (ConLiGen), PsyCourse and Bonn-Mannheim samples were genotyped and their BD and SCZ polygenic risk scores (PRSs) were calculated using the summary statistics of the Psychiatric Genomics Consortium as a training data set. AAO was either separated into onset groups of clinical interest (childhood and adolescence [≤18 years] vs adulthood [>18 years]) or considered as a continuous measure. The associations between BD- and SCZ-PRSs and AAO were evaluated with regression models. RESULTS: BD- and SCZ-PRSs were not significantly associated with age at disease onset. Results remained the same when analyses were stratified by site of recruitment. CONCLUSIONS: The current study is the largest conducted so far to investigate the association between the cumulative BD and SCZ polygenic risk and AAO in BD patients. The reported negative results suggest that such a polygenic influence, if there is any, is not large, and highlight the importance of conducting further, larger scale studies to obtain more information on the genetic architecture of this clinically relevant phenotype. peerReviewed

Published
2018

6. Genes involved in stress response influence lithium efficacy in bipolar patients

Author

Monika Dmitrzak-Weglarz, Janusz K. Rybakowski, Aleksandra Szczepankiewicz, Joanna Twarowska-Hauser, Sebastian Kliwicki, Beata Narozna, Piotr M. Czerski, Joanna Pawlak, and Maria Skibinska

Subjects
Adult, Male, Hypothalamo-Hypophyseal System, medicine.medical_specialty, Linkage disequilibrium, Bipolar Disorder, Lithium (medication), Gene Expression, Pituitary-Adrenal System, Context (language use), Biology, Polymorphism, Single Nucleotide, Linkage Disequilibrium, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Lithium Carbonate, Internal medicine, medicine, Humans, Bipolar disorder, Biological Psychiatry, Aged, Aged, 80 and over, First episode, Mood Disorders, Haplotype, Lithium carbonate, Middle Aged, medicine.disease, 030227 psychiatry, Psychiatry and Mental health, Endocrinology, Haplotypes, chemistry, Female, FKBP5, Stress, Psychological, 030217 neurology & neurosurgery, medicine.drug
Abstract

Objectives In mood disorders, chronic stimulation with stress results in aberrant regulation of the hypothalamic-pituitary-adrenal (HPA) axis. Lithium was shown to influence HPA axis function. The underlying genetic background as well as environmental context may influence the stress response, and therefore lithium efficacy. The aim of the present study was to analyze if genetic variants located in genes involved in HPA axis regulation affect the response to long-term lithium treatment in bipolar patients. Methods We included 93 patients with bipolar disorder (32 males and 61 females), aged 31-80 years. The patients had been treated with lithium carbonate for at least 5 years. The magnitude of the lithium response was assessed using the Alda scale. Genotyping was performed for 28 polymorphisms in the genes encoding the following proteins involved in HPA axis regulation: corticotropin-releasing hormone receptor 1 (CRHR1), arginine vasopressin receptor 1B (AVPR1b), FK506 binding protein (FKBP) 5, FKBP4, BCL2-associated athanogene 1 (BAG1), stress induced phosphoprotein 1 (STIP1), glucocorticoid-induced transcript 1 (GLCC1), dual specificity phosphatase 1 (DUSP1) serine and arginine rich splicing factor (SRSF) 3, SRSF9, SRSF5, and acid phosphatase 1 (ACP1). Linkage disequilibrium and haplotype analysis were then performed, followed by statistical analysis (Statistica v.12; Stasoft, Krakow, Poland). Results We found a correlation between stressful life events at first episode and worse response to lithium (P=.019). In single marker analysis, we observed a significant association between three FKBP5 polymorphisms (rs1360780, rs7748266 and rs9296158), one ACP1 variant (rs300774) and one glucocorticoid-induced transcript 1 gene (GLCC1) variant (rs37972) and the degree of lithium response. Five out of seven FKBP5 polymorphisms showed strong linkage with one haplotype demonstrating an association with lithium efficacy (P=.008). No relationship was found between the other analyzed polymorphisms and lithium response. Conclusion The response to lithium may depend on the variants of genes regulating the HPA axis and stressful life events in bipolar patients.

Published
2018

7. Association between solar insolation and a history of suicide attempts in bipolar I disorder

Author

Bharathram Sathur Raghuraman, Anton A. Mozzhegorov, Erkki Isometsä, Yosra Zgueb, Claire O'Donovan, Peter C. Whybrow, Rasmus Wentzer Licht, Eduard Vieta, Ingrid Melle, Sule Bicakci, Wendy K. Marsh, Julia Veeh, Rikke Krogh, Francisco Diego Rabelo da Ponte, John F. Gottlieb, Philipp Ritter, Fatima Meza-Urzua, Dan J. Stein, Mythily Subramaniam, Biju Viswanath, Ravi Kumar Nadella, Thomas Bjella, Marco Pinna, Kemal Sagduyu, Fabiano G. Nery, Kirsi Suominen, Hiromi Tagata, Mark A. Frye, Martin Alda, Mónica Martínez-Cengotitabengoa, Ole A. Andreassen, Mok Yee Ming, Chantal Henry, Michael Bauer, Scott Monteith, Elias Angelopoulos, Maurício Kunz, Ana González-Pinto, Erik Roj Larsen, Rodrigo A. Munoz, Frank Bellivier, Michael Berk, Mathias Kardell, Andrea Fagiolini, Mikael Landén, Janusz K. Rybakowski, Yavuz Ayhan, Ute Lewitzka, Sebastian Kliwicki, Starlin V. Mythri, Helle Østermark Sørensen, Robert H. Belmaker, Beny Lafer, Harriet Birabwa-Oketcho, Edgar Arrua Vares, Paul W. Stackhouse, Raffaella Ardau, Andreas Reif, René Ernst Nielsen, Jorge Cabrera, Sven Janno, Carlos López-Jaramillo, Ahmad Hatim Sulaiman, Fethi Nacef, Gunnar Morken, Kostas N. Fountoulakis, Arne E. Vaaler, Yoshitaka Tatebayashi, Tasha Glenn, Mirko Manchia, Barbara König, Rita Bauer, Raj Ramesar, Markus Donix, Bruno Etain, Mark Zetin, Danilo Quiroz, Yolanda Pica Ruiz, Slim Khaldi, Carla Torrent, Leonardo Tondo, Christopher Baethge, Sergio Strejilevich, Bernhard T. Baune, Enrica Mosca, Adel Omrani, Christian Simhandl, M. S. Reddy, Seetal Dodd, Maximilian Pilhatsch, Glenda MacQueen, Hirohiko Harima, Claudia Becerra-Palars, Flávio Kapczinski, Timur L. Kot, Paul Grof, Emanuel Severus, Yuly Bersudsky, Natalie L. Rasgon, Eric Yat Wo Cheung, Ângela Miranda Scippa, Maria Del Zompo, Yamima Osher, María Yoldi-Negrete, Uta Ouali, Department of Psychiatry, Clinicum, and HUS Psychiatry

Subjects
Male, Insolation, Internationality, Bipolar I disorder, RETINAL GANGLION-CELLS, MOOD DISORDERS, Substance-Related Disorders, Bipolar disorder, Climate, Seasonal variation, SEASONAL-VARIATION, Equator, Suicide, Attempted, 3124 Neurology and psychiatry, Latitude, 03 medical and health sciences, Sex Factors, 0302 clinical medicine, Risk Factors, medicine, Humans, Age of Onset, Solar insolation, Suicide, Sunlight, VITAMIN-D, SUBSTANCE USE, Biological Psychiatry, RISK, Suicide attempt, AGE-OF-ONSET, Age Factors, Middle Aged, Seasonality, medicine.disease, 030227 psychiatry, SHIFT WORK, Psychiatry and Mental health, Geography, Female, Seasons, CIRCADIAN-RHYTHMS, 030217 neurology & neurosurgery, BEHAVIOR, Demography
Abstract

In many international studies, rates of completed suicide and suicide attempts have a seasonal pattern that peaks in spring or summer. This exploratory study investigated the association between solar insolation and a history of suicide attempt in patients with bipolar I disorder. Solar insolation is the amount of electromagnetic energy from the Sun striking a surface area on Earth. Data were collected previously from 5536 patients with bipolar I disorder at 50 collection sites in 32 countries at a wide range of latitudes in both hemispheres. Suicide related data were available for 3365 patients from 310 onset locations in 51 countries. 1047 (31.1%) had a history of suicide attempt. There was a significant inverse association between a history of suicide attempt and the ratio of mean winter solar insolation/mean summer solar insolation. This ratio is smallest near the poles where the winter insolation is very small compared to the summer insolation. This ratio is largest near the equator where there is relatively little variation in the insolation over the year. Other variables in the model that were positively associated with suicide attempt were being female, a history of alcohol or substance abuse, and being in a younger birth cohort. Living in a country with a state-sponsored religion decreased the association. (All estimated coefficients p

Published
2019

8. Polygenic scores for major depressive disorder and depressive symptoms predict response to lithium in patients with bipolar disorder

Author

Michael McCarthy, Alfonso Tortorella, Jean-Michel Aubry, James B. Potash, Hsi-Chung Chen, Eduard Vieta, Claire Slaney, Frank Bellivier, Claire O'Donovan, Palmiero Monteleone, Alexandre Dayer, Lena Backlund, Michael Bauer, Nina Dalkner, Christian Simhandl, Liping Hou, Katzutaka Shimoda, Cristiana Cruceanu, Janusz K. Rybakowski, Lina Martinsson, Gonzalo Laje, Susan G. Leckband, Andrea Hofmann, Micah Cearns, Eva Z. Reininghaus, Barbara W. Schweizer, Pablo Cervantes, Marcella Rietschel, Ryota Hashimoto, Paul Grof, Tomas Novak, Yi-Hsiang Hsu, Stephanie H. Witt, John R. Kelsoe, Julia Veeh, Thomas Stamm, Francesc Colom, Catharina Lavebratt, Adam Wright, Maria Grigoroiu-Serbanescu, Philip B. Mitchell, Ichiro Kusumi, Sarah Kittel-Schneider, Urs Heilbronner, Julie Garnham, Sven Cichon, Layla Kassem, Norio Ozaki, Piotr M. Czerski, Markus M. Nöthen, Peter Falkai, Bruno Etain, Mirko Manchia, Joanna Hauser, Urban Ösby, Caroline M. Nievergelt, Fasil Tekola-Ayele, Stéphane Jamain, Thomas G. Schulze, Clara Brichant-Petitjean, Antonio Benabarre, Bernhard T. Baune, Esther Jiménez, Joanna M. Biernacka, Paul D. Shilling, Caterina Chillotti, Barbara König, Abesh Kumar Bhattacharjee, Scott R. Clark, Andrea Pfennig, Mazda Adli, Raffaella Ardau, Marina Mitjans, Armin Birner, Andreas Reif, Sergi Papiol, Mario Maj, Giovanni Severino, Martin Schalling, Fernando S. Goes, Susan L. McElroy, Franziska Degenhardt, Louise Frisén, Pavla Stopkova, Peter P. Zandi, J. Raymond DePaulo, Martin Alda, Peter R. Schofield, Per Hoffmann, Susanne Bengesser, Stefan Herms, Klaus Oliver Schubert, Sebastian Kliwicki, Guy A. Rouleau, Andreas J. Forstner, Gustavo Turecki, Bárbara Arias, Azmeraw T. Amare, Marion Leboyer, Maria Del Zompo, Po-Hsiu Kuo, Nirmala Akula, Francis M. Mondimore, Sébastien Gard, Mark A. Frye, Mikael Landén, Alessio Squassina, Jean-Pierre Kahn, Francis J. McMahon, Kazufumi Akiyama, Tadafumi Kato, Tatyana Shekhtman, and Janice M. Fullerton

Subjects
Oncology, medicine.medical_specialty, Lithium (medication), business.industry, Genome-wide association study, Logistic regression, medicine.disease, 030227 psychiatry, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Quartile, Internal medicine, Medicine, Major depressive disorder, Bipolar disorder, business, 030217 neurology & neurosurgery, Depression (differential diagnoses), medicine.drug, Genetic association
Abstract

BackgroundLithium is a first-line medication for bipolar disorder (BD), but only ~30% of patients respond optimally to the drug. Since genetic factors are known to mediate lithium treatment response, we hypothesized whether polygenic susceptibility to the spectrum of depression traits is associated with treatment outcomes in patients with BD. In addition, we explored the potential molecular underpinnings of this relationship.MethodsWeighted polygenic scores (PGSs) were computed for major depressive disorder (MDD) and depressive symptoms (DS) in BD patients from the Consortium on Lithium Genetics (ConLi+Gen; n=2,586) who received lithium treatment. Lithium treatment outcome was assessed using the ALDA scale. Summary statistics from genome-wide association studies (GWAS) in MDD (130,664 cases and 330,470 controls) and DS (n=161,460) were used for PGS weighting. Associations between PGSs of depression traits and lithium treatment response were assessed by binary logistic regression. We also performed a cross-trait meta-GWAS, followed by Ingenuity® Pathway Analysis.OutcomesBD patients with a low polygenic load for depressive traits were more likely to respond well to lithium, compared to patients with high polygenic load (MDD: OR =1.64 [95%CI: 1.26-2.15], lowest vs highest PGS quartiles; DS: OR=1.53 [95%CI: 1.18-2.00]). Associations were significant for type 1, but not type 2 BD. Cross-trait GWAS and functional characterization implicated voltage-gated potassium channels, insulin-related pathways, mitogen-activated protein-kinase (MAPK) signaling, and miRNA expression.InterpretationGenetic loading to depression traits in BD patients lower their odds of responding optimally to lithium. Our findings support the emerging concept of a lithium-responsive biotype in BD.FundingSee attached details

Published
2018
Full Text
View/download PDF

9. Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder: A genome-wide association study

Author

Claire O'Donovan, Gustavo Turecki, Frank Bellivier, Palmiero Monteleone, Tatyana Shekhtman, Bárbara Arias, Paul Grof, Sébastien Gard, Tomas Novak, Maria Del Zompo, Martin Schalling, Sarah Kittel-Schneider, Hsi-Chung Chen, Eduard Vieta, Claire Slaney, Katzutaka Shimoda, J. Raymond DePaulo, Martin Alda, Liping Hou, Kazufumi Akiyama, Louise Frisén, Gonzalo Laje, Maria Grigoroiu-Serbanescu, Mikael Landén, Nirmala Akula, Cristiana Cruceanu, Tadafumi Kato, Marion Leboyer, Lina Martinsson, Alessio Squassina, Andrea Hofmann, James B. Potash, Barbara König, Markus M. Nöthen, Giovanni Severino, Michael McCarthy, Philip B. Mitchell, Mario Maj, Ichiro Kusumi, Caroline M. Nievergelt, Jean-Pierre Kahn, Ryota Hashimoto, Joanna M. Biernacka, Sebastian Kliwicki, Francis J. McMahon, Guy A. Rouleau, Thomas Stamm, Pablo Cervantes, Alexandre Dayer, Julia Volkert, Po-Hsiu Kuo, Urs Heilbronner, Per Hoffmann, Janice M. Fullerton, Raffaella Ardau, Julie Garnham, Scott R. Clark, Layla Kassem, Fasil Tekola-Ayele, Peter R. Schofield, Nina Dalkner, Caterina Chillotti, Susanne Bengesser, Stefan Herms, Klaus Oliver Schubert, Francis M. Mondimore, Alfonso Tortorella, Adam Wright, Joanna Hauser, Peter P. Zandi, Piotr M. Czerski, Eva Z. Reininghaus, Fernando S. Goes, Jean-Michel Aubry, Antonio Benabarre, Bernhard T. Baune, Thomas G. Schulze, Francesc Colom, Marcella Rietschel, Andrea Pfennig, Catharina Lavebratt, Andreas J. Forstner, Paul D. Shilling, Mazda Adli, Armin Birner, Andreas Reif, Mirko Manchia, Susan G. Leckband, Azmeraw T. Amare, Susan L. McElroy, Michael Bauer, Norio Ozaki, Urban Ösby, Janusz K. Rybakowski, Pavla Stopkova, Esther Jiménez, Christian Simhandl, Abesh Kumar Bhattacharjee, Yi-Hsiang Hsu, John R. Kelsoe, Marina Mitjans, Sergi Papiol, Clara Brichant-Petitjean, Mark A. Frye, Stephanie H. Witt, Franziska Degenhardt, Sven Cichon, Bruno Etain, Lena Backlund, Peter Falkai, Barbara W. Schweizer, Stéphane Jamain, Amare, Azmeraw T., Schubert, Klaus Oliver, Hou, Liping, Clark, Scott R., Papiol, Sergi, Heilbronner, Ur, Degenhardt, Franziska, Tekola-Ayele, Fasil, Hsu, Yi-Hsiang, Shekhtman, Tatyana, Adli, Mazda, Akula, Nirmala, Akiyama, Kazufumi, Ardau, Raffaella, Arias, Bã¡rbara, Aubry, Jean-Michel, Backlund, Lena, Bhattacharjee, Abesh Kumar, Bellivier, Frank, Benabarre, Antonio, Bengesser, Susanne, Biernacka, Joanna M., Birner, Armin, Brichant-Petitjean, Clara, Cervantes, Pablo, Chen, Hsi-Chung, Chillotti, Caterina, Cichon, Sven, Cruceanu, Cristiana, Czerski, Piotr M., Dalkner, Nina, Dayer, Alexandre, Del Zompo, Maria, Depaulo, J. Raymond, à tain, Bruno, Falkai, Peter, Forstner, Andreas J., Frisen, Louise, Frye, Mark A., Fullerton, Janice M., Gard, Sã©bastien, Garnham, Julie S., Goes, Fernando S., Grigoroiu-Serbanescu, Maria, Grof, Paul, Hashimoto, Ryota, Hauser, Joanna, Herms, Stefan, Hoffmann, Per, Hofmann, Andrea, Jamain, Stephane, Jimã©nez, Esther, Kahn, Jean-Pierre, Kassem, Layla, Kuo, Po-Hsiu, Kato, Tadafumi, Kelsoe, John, Kittel-Schneider, Sarah, Kliwicki, Sebastian, Kã¶nig, Barbara, Kusumi, Ichiro, Laje, Gonzalo, Landã©n, Mikael, Lavebratt, Catharina, Leboyer, Marion, Leckband, Susan G., Tortorella, Alfonso, Manchia, Mirko, Martinsson, Lina, Mccarthy, Michael J., Mcelroy, Susan, Colom, Francesc, Mitjans, Marina, Mondimore, Francis M., Monteleone, Palmiero, Nievergelt, Caroline M., Nã¶then, Markus M., Novã¡k, Toma, O'Donovan, Claire, Ozaki, Norio, à sby, Urban, Pfennig, Andrea, Potash, James B., Reif, Andrea, Reininghaus, Eva, Rouleau, Guy A., Rybakowski, Janusz K., Schalling, Martin, Schofield, Peter R., Schweizer, Barbara W., Severino, Giovanni, Shilling, Paul D., Shimoda, Katzutaka, Simhandl, Christian, Slaney, Claire M., Squassina, Alessio, Stamm, Thoma, Stopkova, Pavla, Maj, Mario, Turecki, Gustavo, Vieta, Eduard, Volkert, Julia, Witt, Stephanie, Wright, Adam, Zandi, Peter P., Mitchell, Philip B., Bauer, Michael, Alda, Martin, Rietschel, Marcella, Mcmahon, Francis J., Schulze, Thomas G., and Baune, Bernhard T.

Subjects
Male, Oncology, Multifactorial Inheritance, Bipolar Disorder, Lithium (medication), Genome-wide association study, THERAPY, chemistry.chemical_compound, ddc:616.89, 0302 clinical medicine, HLA Antigens, Spectrum disorder, Original Investigation, RISK, Mood stabilizer, Middle Aged, GLYCOGEN-SYNTHASE KINASE-3, 3. Good health, PREVALENCE, Treatment Outcome, Schizophrenia, Psychiatry and Mental Health, Female, Schizophrenic Psychology, Genetic Load, GLYCOGEN-SYNTHASE KINASE-3, CYTOKINE PRODUCTION, PROPHYLACTIC LITHIUM, SPECTRUM DISORDER, RISK, PREVALENCE, METAANALYSIS, GENETICS, THERAPY, PROFILE, medicine.drug, Adult, medicine.medical_specialty, Genotype, GENETICS, medicine.drug_class, PROFILE, PROPHYLACTIC LITHIUM, 03 medical and health sciences, Lithium Carbonate, Internal medicine, mental disorders, medicine, Humans, Bipolar disorder, Psychiatry, METAANALYSIS, SPECTRUM DISORDER, Inflammation, business.industry, Lithium carbonate, Odds ratio, CYTOKINE PRODUCTION, medicine.disease, 030227 psychiatry, chemistry, business, 030217 neurology & neurosurgery, Genome-Wide Association Study
Abstract

IMPORTANCE Lithium is a first-line mood stabilizer for the treatment of bipolar affective disorder (BPAD). However, the efficacy of lithium varies widely, with a nonresponse rate of up to 30%. Biological response markers are lacking. Genetic factors are thought to mediate treatment response to lithium, and there is a previously reported genetic overlap between BPAD and schizophrenia (SCZ). OBJECTIVES To test whether a polygenic score for SCZ is associated with treatment response to lithium in BPAD and to explore the potential molecular underpinnings of this association. DESIGN, SETTING, AND PARTICIPANTS A total of 2586 patients with BPAD who had undergone lithium treatment were genotyped and assessed for long-term response to treatment between 2008 and 2013.Weighted SCZ polygenic scores were computed at different P value thresholds using summary statistics from an international multicenter genome-wide association study (GWAS) of 36 989 individuals with SCZ and genotype data from patients with BPAD from the Consortium on Lithium Genetics. For functional exploration, a cross-trait meta-GWAS and pathway analysis was performed, combining GWAS summary statistics on SCZ and response to treatment with lithium. Data analysis was performed from September 2016 to February 2017. MAIN OUTCOMES AND MEASURES Treatment response to lithiumwas defined on both the categorical and continuous scales using the Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder score. The effect measures include odds ratios and the proportion of variance explained. RESULTS Of the 2586 patients in the study (mean [SD] age, 47.2 [13.9] years), 1478 were women and 1108 were men. The polygenic score for SCZ was inversely associated with lithium treatment response in the categorical outcome, at a threshold P < 5 ? 10-2. Patients with BPAD who had a low polygenic load for SCZ responded better to lithium, with odds ratios for lithium response ranging from 3.46 (95%CI, 1.42-8.41) at the first decile to 2.03 (95%CI, 0.86-4.81) at the ninth decile, compared with the patients in the 10th decile of SCZ risk. In the cross-trait meta-GWAS, 15 genetic loci that may have overlapping effects on lithium treatment response and susceptibility to SCZ were identified. Functional pathway and network analysis of these loci point to the HLA antigen complex and inflammatory cytokines. CONCLUSIONS AND RELEVANCE This study provides evidence for a negative association between high genetic loading for SCZ and poor response to lithium in patients with BPAD. These results suggest the potential for translational research aimed at personalized prescribing of lithium.

Published
2018

10. High genetic loading of schizophrenia predicts poor response to lithium in patients with bipolar disorder: A polygenic score and cross-trait genetic analysis

Author

Peter R. Schofield, Susanne Bengesser, Stefan Herms, Klaus Oliver Schubert, Susan G. Leckband, Maria Grigoroiu-Serbanescu, Scott R. Clark, Michael McCarthy, Thomas Stamm, Michael Bauer, Marion Leboyer, Layla Kassem, Fasil Tekola-Ayele, Caterina Chillotti, Andrea Hofmann, Fernando S. Goes, Urs Heilbronner, Tomas Novak, Francesc Colom, Philip B. Mitchell, Janusz K. Rybakowski, Alexandre Dayer, Piotr M. Czerski, Kazufumi Akiyama, Antonio Benabarre, Bernhard T. Baune, Sarah Kittel-Schneider, Nina Dalkner, Gustavo Turecki, Raffaella Ardau, Sébastien Gard, Gonzalo Laje, Mark A. Frye, Tadafumi Kato, Bárbara Arias, Norio Ozaki, Francis M. Mondimore, Per Hoffmann, Hsi-Chung Chen, Claire Slaney, Eva Z. Reininghaus, Andrea Pfennig, Susan L. McElroy, Katzutaka Shimoda, Louise Frisén, Peter P. Zandi, Maria Del Zompo, Nirmala Akula, Ryota Hashimoto, Catharina Lavebratt, Cristiana Cruceanu, Pavla Stopkova, Ichiro Kusumi, Paul Grof, Andreas J. Forstner, Janice M. Fullerton, Julie Garnham, Mikael Landén, Giovanni Severino, Paul D. Shilling, Mazda Adli, Armin Birner, Alessio Squassina, Frank Bellivier, Alfonso Tortorella, Lina Martinsson, Palmiero Monteleone, Jean-Michel Aubry, James B. Potash, Pablo Cervantes, Jean-Pierre Kahn, Francis J. McMahon, Po-Hsiu Kuo, Tatyana Shekhtman, Mirko Manchia, Joanna M. Biernacka, Barbara König, J. Raymond DePaulo, Martin Alda, Joanna Hauser, Christian Simhandl, Yi-Hsiang Hsu, John R. Kelsoe, Clara Brichant-Petitjean, Azmeraw T. Amare, Peter Falkai, Stéphane Jamain, Franziska Degenhardt, Marcella Rietschel, Stephanie H. Witt, Markus M. Nöthen, Caroline M. Nievergelt, Eduard Vieta, Liping Hou, Sven Cichon, Julia Volkert, Bruno Etain, Lena Backlund, Barbara W. Schweizer, Urban Ösby, Esther Jiménez, Abesh Kumar Bhattacharjee, Marina Mitjans, Sergi Papiol, Mario Maj, Adam Wright, Thomas G. Schulze, Martin Schalling, Sebastian Kliwicki, Guy A. Rouleau, Andreas Reif, and Claire O'Donovan

Subjects
Oncology, medicine.medical_specialty, Lithium (medication), business.industry, medicine.drug_class, Genome-wide association study, Mood stabilizer, Odds ratio, medicine.disease, 3. Good health, 030227 psychiatry, Treatment of bipolar disorder, 03 medical and health sciences, 0302 clinical medicine, Schizophrenia, Internal medicine, Pharmacogenomics, mental disorders, medicine, Bipolar disorder, business, 030217 neurology & neurosurgery, medicine.drug
Abstract

ImportanceLithium is a first-line mood stabilizer for the maintenance treatment of Bipolar Disorder (BPD). However, the efficacy of lithium varies widely, with a non-response rate of up to 30%. Biological response markers and predictors are lacking.ObjectiveGenetic factors are thought to mediate lithium treatment response, and the previously reported genetic overlap between BPD and schizophrenia (SCZ) led us to test whether a polygenic score (PGS) for SCZ could predict lithium treatment response in BPD. Further, we explored the potential molecular underpinnings of this association.DesignWeighted SCZ PGSs were computed at ten p-value thresholds (PT) using summary statistics from a genome-wide association study (GWAS) of 36,989 SCZ cases, and genotype data for BPD patients from the Consortium on Lithium Genetics (ConLi+Gen). For functional exploration, we performed a cross-trait meta-GWAS and pathway analysis, combining GWAS summary statistics on SCZ and lithium treatment response.SettingInternational multicenter GWAS.ParticipantsPatients with BPD who had undergone lithium treatment were genotyped and retrospectively assessed for long-term treatment response (n=2,586).Main outcome measuresClinical treatment response to lithium was defined on both the categorical and continuous scales using the ALDA score. The effect measures include odds ratios (ORs) and the proportion of variance explained (R2), and a significant association was determined at pResultsThe PGS for SCZ was inversely associated with lithium treatment response in the categorical outcome (p=8×10−5), at PT−2. Patients with BPD who had low polygenic load for SCZ responded better to lithium, with ORs for lithium response ranging from 3.46 [95%CI: 1.42-8.41 at 1stdecile] to 2.03 [95%CI: 0.86-4.81 at the 9th decile], compared to the patients in the 10thdecile of SCZ risk. In the cross-trait meta-GWAS, 15 genetic loci that may have overlapping effects on lithium treatment response and susceptibility to SCZ were identified. Functional pathway and network analysis of these loci point to the HLA complex and inflammatory cytokines (TNFα, IL-4, IFNγ) as molecular contributors to lithium treatment response in BPD.Conclusions and RelevanceThe study provides, for the first-time, evidence for a negative association between high genetic loading for SCZ and poor response to lithium in patients with BPD. These results suggest the potential for translational research aimed at personalized prescribing of lithium.Key PointsQuestionDoes a polygenic score for Schizophrenia (SCZ) predict response to lithium in patients with Bipolar Disorder (BPD)? What are the molecular drivers of the association between SCZ and lithium treatment response?FindingsWe found an inverse association between genetic loading for SCZ risk variants and response to lithium in patients with BPD. Genetic variants in the HLA region on chromosome 6, the antigen presentation pathway and markers of inflammation (TNFα, IL-4, IFNγ) point to molecular underpinnings of lithium treatment response in BPD.MeaningIn patients with BPD, an assessment of a polygenic load for SCZ risk variants may assist in conjunction with clinical data to predict whether they would respond to lithium treatment.

Published
2017

11. Solar insolation in springtime influences age of onset of bipolar I disorder

Author

Christian Simhandl, Harriet Birabwa-Oketcho, Slim Khaldi, Claire O'Donovan, Ahmad Hatim Sulaiman, Janusz K. Rybakowski, Dan J. Stein, M. S. Reddy, Rasmus Wentzer Licht, Andreas Reif, Flávio Kapczinski, Y. Pica Ruiz, Ângela Miranda Scippa, Christopher Baethge, Julia Veeh, M. Yee Ming, Kemal Sagduyu, Hiromi Tagata, Biju Viswanath, F. D. R. da Ponte, Scott Monteith, Michael Bauer, Mark A. Frye, Yamima Osher, Raffaella Ardau, Ana González-Pinto, Yoshitaka Tatebayashi, Chantal Henry, Sven Janno, M. A. Aleksandrovich, Timur L. Kot, Beny Lafer, Paul Grof, Yavuz Ayhan, René Ernst Nielsen, Barbara König, Eduard Vieta, Emanuel Severus, Erik Roj Larsen, Kirsi Suominen, Sebastian Kliwicki, Eric Yat Wo Cheung, Peter C. Whybrow, H. Østermark Sørensen, John F. Gottlieb, Mikael Landén, Michael Berk, Andrea Fagiolini, M. Del Zompo, Juan Cabrera, Carlos López-Jaramillo, Mirko Manchia, Tasha Glenn, Ingrid Melle, Starlin V. Mythri, Sule Bicakci, Rita Bauer, Maximilian Pilhatsch, Rodrigo A. Munoz, Danilo Quiroz, Glenda MacQueen, Philipp Ritter, Hirohiko Harima, Ravi Kumar Nadella, Enrica Mosca, Yuly Bersudsky, Natalie L. Rasgon, Wendy K. Marsh, Konstantinos N. Fountoulakis, María Yoldi-Negrete, Adel Omrani, Mathias Kardell, Fatima Meza-Urzua, Letizia Bossini, Fethi Nacef, Franck Bellivier, Erkki Isometsä, Gunnar Morken, Elias Angelopoulos, Marco Pinna, Thomas Bjella, Fabiano G. Nery, Sergio Strejilevich, Markus Donix, Bernhard T. Baune, Ole A. Andreassen, Leonardo Tondo, Rajkumar Ramesar, Claudia Becerra-Palars, Arne E. Vaaler, Yosra Zgueb, Uta Ouali, Seetal Dodd, Rikke Krogh, Ute Lewitzka, Maurício Kunz, S. R. Bharathram, Bruno Etain, Carla Torrent, Mythily Subramaniam, Robert H. Belmaker, Martin Alda, Mónica Martínez-Cengotitabengoa, Mark Zetin, Ben Hassine, AbdelHakim, University Hospital Carl Gustav Carus [Dresden, Germany], Technische Universität Dresden = Dresden University of Technology (TU Dresden), ChronoRecord Association Inc. [Fullerton, USA], Dalhousie University [Halifax], Soviet Psychoneurological Hospital [Urai, Russia], Norwegian Centre for Mental Disorders Research [Oslo] (NORMENT), University of Oslo (UiO)-Haukeland University Hospital, University of Bergen (UiB)-University of Bergen (UiB)-Oslo University Hospital [Oslo], University of Athens Medical School [Athens], Università degli Studi di Cagliari = University of Cagliari (UniCa), Faculty of Medicine [Hacettepe University], Hacettepe University = Hacettepe Üniversitesi, Faculty of Medicine [Cologne], University Hospital of Cologne [Cologne]-University of Cologne, National Institute of Mental Health and Neurosciences [Bangalore, Inde] (NIMHANS ), Adelaide Medical School [Australia], University of Adelaide, National Institute of Psychiatry Ramón de la Fuente Muñiz [Mexico City] (INPRF), Variabilité de réponse aux Psychotropes (VariaPsy - U1144), Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Ben-Gurion University of the Negev (BGU), Deakin University [Burwood], University of Melbourne, Butabika Hospital [Kampala, Uganda], Università degli Studi di Siena = University of Siena (UNISI), Mood Disorders Clinic, Dr. Jose Horwitz Psychiatric Institute, Castle Peak Hospital [Hong Kong], Centre for Innovation in Mental and Physical Health and Clinical Treatment [Geelong Victoria, Australia] (IMPACT), Aristotle University of Thessaloniki, Mayo Clinic [Rochester], University of the Basque Country/Euskal Herriko Unibertsitatea (UPV/EHU), Northwestern University Feinberg School of Medicine, Mood Disorders Center of Ottawa (MDCO), University of Ottawa [Ottawa], Kobe University, Tokyo Metropolitan Matsuzawa Hospital [Tokyo, Japan], Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Perception et Mémoire / Perception and Memory, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), National Institute for Health and Welfare [Helsinki], Helsingin yliopisto = Helsingfors universitet = University of Helsinki, University of Tartu, Universidade Federal do Rio Grande do Sul [Porto Alegre] (UFRGS), Institute of Neuroscience and Physiology [Göteborg], Poznan University of Medical Sciences [Poland] (PUMS), BIPOLAR Zentrum Wiener Neustadt [Wiener Neustadt, Austria], Khanty-Mansiysk Clinical Psychoneurological Hospital [Khanty-Mansiysk, Russia], Aarhus University Hospital, Universidade de São Paulo Medical School (FMUSP), Karolinska Institutet [Stockholm], Aalborg University [Denmark] (AAU), Universidad de Antoquia, University of Calgary, University of Massachusetts Medical School [Worcester] (UMASS), University of Massachusetts System (UMASS), Institute of Mental Health [Singapore], Michigan State University [Traverse City], Michigan State University System, Department of Psychiatry [St. Olav's hospital, Trondheim], St. Olav's Hospital, Norwegian University of Science and Technology [Trondheim] (NTNU), Norwegian University of Science and Technology (NTNU), University of California [San Diego] (UC San Diego), University of California (UC), Asha Bipolar Clinic [Hyderabad, Telangana, India] (ABC), Université de Tunis El Manar (UTM), Faculté de Médecine de Tunis, Hospital Ángeles del Pedregal [Mexico City, Mexico], Centro Lucio Bini [Cagliari, Italy], Universidad Diego Portales [Santiago] (UDP), Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Stanford University School of Medicine [CA, USA], Goethe-Universität Frankfurt am Main, University of Missouri [Kansas City] (UMKC), University of Missouri System, Universidade Federal da Bahia (UFBA), Institute of Neuroscience Foundation Favaloro, Favaloro Foundation, Faculty of Medicine, University of Malaya [Kuala Lumpur, Malaisie], University of Malaya = Universiti Malaya [Kuala Lumpur, Malaisie] (UM), Tokyo Metropolitan Institute of Medical Science (TMIMS), McLean Hospital [Belmont, Ma.], University of Barcelona, Goethe-University Frankfurt am Main, Universitätsklinikum Frankfurt, Consejo Nacional de Ciencia y Tecnología [Mexico] (CONACYT), Chapman University, Semel Institute for Neuroscience and Human Behavior [Los Angeles, Ca], University of California [Los Angeles] (UCLA), University of California (UC)-University of California (UC), Michael Berk is supported by an NHMRC Senior Principal Research Fellowship (1059660). Ole A Andreassen, Thomas DBjella and Ingrid Melle are supported by Research Council of Norway (223273) and KG Jebsen Stiftelsen. Ravi Nadella has received funding from the Accelerator program for Discovery in Brain disorders using Stem cells (ADBS), jointly funded by the Department of Biotechnology, Government of India, and the Pratiksha trust. Biju Viswanath has received funding by Department of Science and Technology INSPIRE scheme, Government of India. Mikael Landén was supported by grants from the Swedish Research Council (K2014‐62X‐14647‐12‐51 and K2010‐61P‐21568‐01‐4), the Swedish foundation for Strategic Research (KF10‐0039), and the Swedish Federal Government under the LUA/ALF agreement (ALF 20130032, ALFGBG‐142041)., We thank Haydeh Olofsson for valuable data management support., Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Tokyo Metropolitan Institute of Medical Science, Universita degli Studi di Cagliari [Cagliari], University of the Basque Country [Bizkaia] (UPV/EHU), University of Helsinki, University of California, University of Malaya [Kuala Lumpur, Malaisie], University of California-University of California, University of Cologne-University Hospital of Cologne [Cologne], and Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-IFR10

Subjects
Male, Internationality, Bipolar I disorder, Epidemiology, [SDV]Life Sciences [q-bio], 0302 clinical medicine, MESH: Asia/epidemiology, Age of Onset, Family history, First episode, MESH: Middle Aged, Circadian rhythm, Electromagnetic Radiation, MESH: Australia/epidemiology, Middle Aged, MESH: Seasons, 3. Good health, Europe, [SDV] Life Sciences [q-bio], MESH: Young Adult, Psychiatry and Mental Health, Solar insolation, Sunlight, Female, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Seasons, Solar System, medicine.symptom, Mania, Adult, MESH: Sunlight, Asia, Adolescent, Bipolar disorder, MESH: Electromagnetic Radiation, MESH: Age of Onset, MESH: Solar System, MESH: Internationality, Young Adult, 03 medical and health sciences, MESH: Bipolar Disorder/epidemiology, MESH: South America/epidemiology, medicine, Journal Article, Humans, [SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], MESH: Adolescent, MESH: Humans, business.industry, Australia, MESH: North America/epidemiology, MESH: Adult, South America, medicine.disease, MESH: Africa/epidemiology, MESH: Male, 030227 psychiatry, MESH: Europe/epidemiology, Mood disorders, 13. Climate action, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Africa, North America, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Age of onset, business, MESH: Female, 030217 neurology & neurosurgery, Demography
Abstract

OBJECTIVE: To confirm prior findings that the larger the maximum monthly increase in solar insolation in springtime, the younger the age of onset of bipolar disorder.METHOD: Data were collected from 5536 patients at 50 sites in 32 countries on six continents. Onset occurred at 456 locations in 57 countries. Variables included solar insolation, birth-cohort, family history, polarity of first episode and country physician density.RESULTS: There was a significant, inverse association between the maximum monthly increase in solar insolation at the onset location, and the age of onset. This effect was reduced in those without a family history of mood disorders and with a first episode of mania rather than depression. The maximum monthly increase occurred in springtime. The youngest birth-cohort had the youngest age of onset. All prior relationships were confirmed using both the entire sample, and only the youngest birth-cohort (all estimated coefficients P < 0.001).CONCLUSION: A large increase in springtime solar insolation may impact the onset of bipolar disorder, especially with a family history of mood disorders. Recent societal changes that affect light exposure (LED lighting, mobile devices backlit with LEDs) may influence adaptability to a springtime circadian challenge.

Published
2017

12. Polymorphism of circadian clock genes and prophylactic lithium response

Author

Sebastian Kliwicki, Janusz K. Rybakowski, Joanna Hauser, and Monika Dmitrzak-Weglarz

Subjects
Adult, Male, Bipolar Disorder, Genotype, Timeless, Period (gene), Circadian clock, CLOCK Proteins, Cell Cycle Proteins, Lithium, Biology, Polymorphism, Single Nucleotide, ARNTL Gene, Antimanic Agents, Circadian Clocks, Humans, Genetic Predisposition to Disease, Genetic Association Studies, Biological Psychiatry, Aged, Retrospective Studies, Aged, 80 and over, Genetics, ARNTL Transcription Factors, Intracellular Signaling Peptides and Proteins, Period Circadian Proteins, Middle Aged, ARNTL, CLOCK, Psychiatry and Mental health, PER3, Pharmacogenetics, Female
Abstract

Objectives The therapeutic action of lithium in bipolar mood disorder may be connected with its effect on biological rhythms. In the present study, an attempt was made to investigate an association between multiple single nucleotide polymorphisms (SNPs) and their haplotypes pertaining to four genes involved in regulation of biological rhythms [circadian locomotor output cycle kaput (CLOCK), aryl hydrocarbon receptor nuclear translocator-like (ARNTL), timeless circadian clock (TIMELESS), period circadian clock 3 (PER 3)], and the efficacy of lithium prophylaxis. Methods The study was performed on 115 patients with bipolar mood disorder (45 males, 70 females) with a mean age of 52 ± 12 years, with lithium prophylaxis for 22 ± 8 years, recruited from the outpatients in the Department of Psychiatry, Poznan University of Medical Sciences. The assessment of the lithium prophylactic response was made retrospectively using the Alda scale. Genotyping was done for nine SNPs of the CLOCK gene, 18 SNPs of the ARNTL gene, six SNPs of the timeless circadian clock (TIM) gene, and nine SNPs of the PER3 gene. Results An association with the degree of lithium prophylaxis was found for six SNPs and three haplotype blocks of the ARNTL gene, and two SNPs and one haplotype block of the TIM gene. No association with SNPs or haplotypes of the CLOCK and PER3 genes was observed. Conclusions The results suggest that the ARNTL and TIM genes may be associated with the lithium prophylactic response in bipolar illness. This association may be related to the role of these genes in the predisposition to bipolar mood disorder. Of special interest may be polymorphisms of these genes involved both in the predisposition to bipolar mood disorder and the lithium response.

Published
2013

13. Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder

Author

Christina M. Hultman, Peter R. Schofield, J. Raymond DePaulo, Martin Alda, Szabolcs Szelinger, Susanne Bengesser, Stefan Herms, Alessio Squassina, Gustavo Turecki, Barbara König, Fabian Streit, Jana Strohmaier, Martin Schalling, Maren Lang, Michael McCarthy, Per Hoffmann, Sarah K. Tighe, William Byerley, Jean-Pierre Kahn, Bárbara Arias, Alfonso Tortorella, Francis J. McMahon, William Lawson, Gonzalo Laje, Wade H. Berrettini, Tatyana Shekhtman, Jean-Michel Aubry, Erin N. Smith, Peng Zhang, Stefanie Heilmann-Heimbach, Evaristus A. Nwulia, Thomas B. Barrett, Cinnamon S. Bloss, Nicholas J. Schork, Tatiana Foroud, Antonio Benabarre, Bernhard T. Baune, William Coryell, Giovanni Severino, Sébastien Gard, Michael Bauer, Layla Kassem, Judith A. Badner, Peter P. Zandi, Rebecca McKinney, Paul D. Shilling, Mazda Adli, Pablo Cervantes, John P. Rice, Nirmala Akula, Marcella Rietschel, Maria Grigoroiu-Serbanescu, Armin Birner, David Craig, Caterina Chillotti, Sebastian Kliwicki, Guy A. Rouleau, Alexandre Dayer, Claire Slaney, Thomas Stamm, Piotr M. Czerski, Pamela B. Mahon, Elliot S. Gershon, Susan L. McElroy, Andreas J. Forstner, Sarah E. Bergen, Peter Propping, Johannes Schumacher, Mikael Landén, Marion Leboyer, Janusz K. Rybakowski, Cristiana Cruceanu, Urs Heilbronner, Joanna Hauser, Fernando S. Goes, Howard J. Edenberg, Markus M. Nöthen, Adam Wright, Chunyu Liu, Daniel L. Koller, James B. Potash, Elise T. Bui, Julie Garnham, Caroline M. Nievergelt, William A. Scheftner, Lina Martinsson, Janice M. Fullerton, Maria Del Zompo, Shashi Hitturlingappa, Mirko Manchia, Andreas Reif, Andrea Pfennig, Thomas G. Schulze, Eduard Vieta, Jie Song, Liping Hou, Maria Hipolito, John I. Nurnberger, Louise Frisén, Anna Maaser, Wolfgang Maier, Thomas W. Mühleisen, Andrea Hofmann, Philip B. Mitchell, Clara Brichant-Petitjean, Raffaella Ardau, Joanna M. Biernacka, N. Lackner, Eva Z. Reininghaus, Francesc Colom, Catharina Lavebratt, Francis M. Mondimore, Urban Ösby, Esther Jiménez, Abesh Kumar Bhattacharjee, Marina Mitjans, Tiffany A. Greenwood, Peter Falkai, Stephanie H. Witt, Stéphane Jamain, Sven Cichon, Julia Volkert, Bruno Etain, Lena Backlund, Tomas Novak, Sarah Kittel-Schneider, Franziska Degenhardt, Barbara W. Schweizer, Mark A. Frye, Christian Simhandl, John R. Kelsoe, Sebastian Zöllner, Frank Bellivier, Palmiero Monteleone, Tony Davis, Susan G. Leckband, Mario Maj, Melvin G. McInnis, and Pavla Stopkova

Subjects
Genetics, 0303 health sciences, Genome-wide association study, Odds ratio, Biology, Heritability, medicine.disease, Mental illness, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Intergenic region, Mood, medicine, Bipolar disorder, 030217 neurology & neurosurgery, 030304 developmental biology, Genetic association
Abstract

Bipolar disorder (BD) is a genetically complex mental illness characterized by severe oscillations of mood and behavior. Genome-wide association studies (GWAS) have identified several risk loci that together account for a small portion of the heritability. To identify additional risk loci, we performed a two-stage meta-analysis of >9 million genetic variants in 9,784 bipolar disorder patients and 30,471 controls, the largest GWAS of BD to date. In this study, to increase power we used ~2,000 lithium-treated cases with a long-term diagnosis of BD from the Consortium on Lithium Genetics, excess controls, and analytic methods optimized for markers on the X-chromosome. In addition to four known loci, results revealed genome-wide significant associations at two novel loci: an intergenic region on 9p21.3 (rs12553324, p = 5.87×10−9; odds ratio = 1.12) and markers within ERBB2 (rs2517959, p = 4.53×10−9; odds ratio = 1.13). No significant X-chromosome associations were detected and X-linked markers explained very little BD heritability. The results add to a growing list of common autosomal variants involved in BD and illustrate the power of comparing well-characterized cases to an excess of controls in GWAS.

Published
2016
Full Text
View/download PDF

14. Genetic variants associated with response to lithium treatment in bipolar disorder:a genome-wide association study

Author

Ryota Hashimoto, Andrea Hofmann, Gustavo Turecki, N. Lackner, Philip B. Mitchell, Bárbara Arias, Urban Ösby, J. Raymond DePaulo, Martin Alda, Julie Garnham, Esther Jiménez, Abesh Kumar Bhattacharjee, Peter P. Zandi, Clara Brichant-Petitjean, Frank Bellivier, Marina Mitjans, Palmiero Monteleone, Eduard Vieta, Liping Hou, Eva Z. Reininghaus, Raffaella Ardau, Paul D. Shilling, Mazda Adli, Armin Birner, Marion Leboyer, Lena Backlund, Andreas J. Forstner, David A. Cousins, Francesc Colom, Catharina Lavebratt, K Oliver Schubert, Barbara W. Schweizer, Mario Maj, Kazufumi Akiyama, Antoni Benabarre, Julia Volkert, Alessio Squassina, Marcella Rietschel, Stephanie H. Witt, Gonzalo Laje, Louise Frisén, Jordan W. Smoller, Paul Grof, Tomas Novak, L. Trevor Young, Sven Cichon, Bruno Etain, Ichiro Kusumi, Sarah K. Tighe, Sarah Kittel-Schneider, Florian Seemüller, Jean-Pierre Kahn, Markus M. Nöthen, Tadafumi Kato, Alexandre Dayer, Caroline M. Nievergelt, Mirko Manchia, Francis J. McMahon, Peter R. Schofield, Susanne Bengesser, Po-Hsiu Kuo, Stefan Herms, Scott R. Clark, Piotr M. Czerski, Oliver Gruber, Franziska Degenhardt, Mark A. Frye, Joanna M. Biernacka, Christian Simhandl, Guo-Bo Chen, Adam Wright, Sébastien Gard, Peter Falkai, Carlos Jaramillo, Stéphane Jamain, Roy H. Perlis, Andrea Pfennig, Tatyana Shekhtman, Maria Del Zompo, Clarissa de Rosalmeida Dantas, Thomas G. Schulze, Alfonso Tortorella, Francis M. Mondimore, John R. Kelsoe, Jean-Michel Aubry, Mikael Landén, Andreas Reif, Naomi R. Wray, Martin Schalling, Janice M. Fullerton, Nirmala Akula, Claudio E. M. Banzato, Elise T. Bui, Per Hoffmann, Sebastian Kliwicki, Guy A. Rouleau, Maria Grigoroiu-Serbanescu, Glenda MacQueen, Lina Martinsson, Giovanni Severino, Norio Ozaki, Daniela Reich-Erkelenz, Layla Kassem, Manuel Mattheisen, Pavla Stopkova, Michael Bauer, Caterina Chillotti, Kazutaka Shimoda, Bernhard T. Baune, Janusz K. Rybakowski, Thomas Stamm, Joanna Hauser, Fernando S. Goes, Urs Heilbronner, James B. Potash, Susan L. McElroy, Barbara König, Susan G. Leckband, Michael McCarthy, Hsi-Chung Chen, Claire Slaney, Cristiana Cruceanu, Pablo Cervantes, Hou, Liping, Heilbronner, Ur, Degenhardt, Franziska, Adli, Mazda, Akiyama, Kazufumi, Akula, Nirmala, Ardau, Raffaella, Arias, Bárbara, Backlund, Lena, Banzato, Claudio E M, Benabarre, Antoni, Bengesser, Susanne, Bhattacharjee, Abesh Kumar, Biernacka, Joanna M, Birner, Armin, Brichant-Petitjean, Clara, Bui, Elise T, Cervantes, Pablo, Chen, Guo-Bo, Chen, Hsi-Chung, Chillotti, Caterina, Cichon, Sven, Clark, Scott R, Colom, Francesc, Cousins, David A, Cruceanu, Cristiana, Czerski, Piotr M, Dantas, Clarissa R, Dayer, Alexandre, Étain, Bruno, Falkai, Peter, Forstner, Andreas J, Frisén, Louise, Fullerton, Janice M, Gard, Sébastien, Garnham, Julie S, Goes, Fernando S, Grof, Paul, Gruber, Oliver, Hashimoto, Ryota, Hauser, Joanna, Herms, Stefan, Hoffmann, Per, Hofmann, Andrea, Jamain, Stephane, Jiménez, Esther, Kahn, Jean-Pierre, Kassem, Layla, Kittel-Schneider, Sarah, Kliwicki, Sebastian, König, Barbara, Kusumi, Ichiro, Lackner, Nina, Laje, Gonzalo, Landén, Mikael, Lavebratt, Catharina, Leboyer, Marion, Leckband, Susan G, Jaramillo, Carlos A López, Macqueen, Glenda, Manchia, Mirko, Martinsson, Lina, Mattheisen, Manuel, Mccarthy, Michael J, Mcelroy, Susan L, Mitjans, Marina, Mondimore, Francis M, Monteleone, Palmiero, Nievergelt, Caroline M, Nöthen, Markus M, Ösby, Urban, Ozaki, Norio, Perlis, Roy H, Pfennig, Andrea, Reich-Erkelenz, Daniela, Rouleau, Guy A, Schofield, Peter R, Schubert, K Oliver, Schweizer, Barbara W, Seemüller, Florian, Severino, Giovanni, Shekhtman, Tatyana, Shilling, Paul D, Shimoda, Kazutaka, Simhandl, Christian, Slaney, Claire M, Smoller, Jordan W, Squassina, Alessio, Stamm, Thoma, Stopkova, Pavla, Tighe, Sarah K, Tortorella, Alfonso, Turecki, Gustavo, Volkert, Julia, Witt, Stephanie, Wright, Adam, Young, L Trevor, Zandi, Peter P, Potash, James B, Depaulo, J Raymond, Bauer, Michael, Reininghaus, Eva Z, Novák, Toma, Aubry, Jean-Michel, Maj, Mario, Baune, Bernhard T, Mitchell, Philip B, Vieta, Eduard, Frye, Mark A, Rybakowski, Janusz K, Kuo, Po-Hsiu, Kato, Tadafumi, Grigoroiu-Serbanescu, Maria, Reif, Andrea, Del Zompo, Maria, Bellivier, Frank, Schalling, Martin, Wray, Naomi R, Kelsoe, John R, Alda, Martin, Rietschel, Marcella, Mcmahon, Francis J, and Schulze, Thomas G

Subjects
Male, Glial Cell Line-Derived Neurotrophic Factor Receptors, Bipolar Disorder, Genotype, Genome-wide association study, Single-nucleotide polymorphism, Bipolar Disorder/drug therapy/genetics, Polymorphism, Single Nucleotide, Article, 03 medical and health sciences, ddc:616.89, 0302 clinical medicine, Genetic variation, Medicine, Humans, Bipolar disorder, Prospective Studies, Allele, Polymorphism, Lithium Compounds/therapeutic use, Genetics, business.industry, Medicine (all), Genetic Variation, General Medicine, Single Nucleotide, Middle Aged, medicine.disease, Polymorphism, Single Nucleotide/genetics, 030227 psychiatry, 3. Good health, Phenotype, Treatment Outcome, Female, Genome-Wide Association Study, Lithium Compounds, business, 030217 neurology & neurosurgery, Imputation (genetics), Pharmacogenetics, Glial Cell Line-Derived Neurotrophic Factor Receptors/genetics
Abstract

BACKGROUND: Lithium is a first-line treatment in bipolar disorder, but individual response is variable. Previous studies have suggested that lithium response is a heritable trait. However, no genetic markers of treatment response have been reproducibly identified.METHODS: Here, we report the results of a genome-wide association study of lithium response in 2563 patients collected by 22 participating sites from the International Consortium on Lithium Genetics (ConLiGen). Data from common single nucleotide polymorphisms (SNPs) were tested for association with categorical and continuous ratings of lithium response. Lithium response was measured using a well established scale (Alda scale). Genotyped SNPs were used to generate data at more than 6 million sites, using standard genomic imputation methods. Traits were regressed against genotype dosage. Results were combined across two batches by meta-analysis.FINDINGS: A single locus of four linked SNPs on chromosome 21 met genome-wide significance criteria for association with lithium response (rs79663003, p=1·37 × 10(-8); rs78015114, p=1·31 × 10(-8); rs74795342, p=3·31 × 10(-9); and rs75222709, p=3·50 × 10(-9)). In an independent, prospective study of 73 patients treated with lithium monotherapy for a period of up to 2 years, carriers of the response-associated alleles had a significantly lower rate of relapse than carriers of the alternate alleles (p=0·03268, hazard ratio 3·8, 95% CI 1·1-13·0).INTERPRETATION: The response-associated region contains two genes for long, non-coding RNAs (lncRNAs), AL157359.3 and AL157359.4. LncRNAs are increasingly appreciated as important regulators of gene expression, particularly in the CNS. Confirmed biomarkers of lithium response would constitute an important step forward in the clinical management of bipolar disorder. Further studies are needed to establish the biological context and potential clinical utility of these findings.FUNDING: Deutsche Forschungsgemeinschaft, National Institute of Mental Health Intramural Research Program.

Published
2016

15. Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder

Author

Philip B. Mitchell, Clara Brichant-Petitjean, Raffaella Ardau, Peter R. Schofield, Susanne Bengesser, Stefan Herms, Sebastian Zöllner, Christina M. Hultman, Shashi Hitturlingappa, Maria Hipolito, Louise Frisén, Thomas W. Mühleisen, Layla Kassem, Christian Simhandl, Urban Ösby, Frank Bellivier, Peter Falkai, Alessio Squassina, Jana Strohmaier, Esther Jiménez, Palmiero Monteleone, Caterina Chillotti, Stéphane Jamain, Peter P. Zandi, Abesh Kumar Bhattacharjee, Tony Davis, Sarah K. Tighe, William Byerley, Jean-Pierre Kahn, Michael Bauer, Nicholas J. Schork, Joanna Hauser, Andreas J. Forstner, Francis J. McMahon, Peter Propping, Marina Mitjans, Tiffany A. Greenwood, Alfonso Tortorella, Fernando S. Goes, Szabolcs Szelinger, Tomas Novak, Erin N. Smith, Andrea Pfennig, Susan G. Leckband, Pablo Cervantes, Sarah Kittel-Schneider, Sébastien Gard, Adam Wright, Tatiana Foroud, Joanna M. Biernacka, Jean-Michel Aubry, Marcella Rietschel, Elliot S. Gershon, Janusz K. Rybakowski, John R. Kelsoe, Stephanie H. Witt, Elise T. Bui, Sarah E. Bergen, Tatyana Shekhtman, Thomas G. Schulze, Sven Cichon, Julia Volkert, Thomas Stamm, Eduard Vieta, Jie Song, Liping Hou, Markus M. Nöthen, Bruno Etain, Mikael Landén, Caroline M. Nievergelt, Mirko Manchia, William Coryell, Howard J. Edenberg, Andreas Reif, Urs Heilbronner, Gonzalo Laje, Lena Backlund, Wade H. Berrettini, Martin Schalling, Franziska Degenhardt, Susan L. McElroy, Mario Maj, Francis M. Mondimore, Peng Zhang, Stefanie Heilmann-Heimbach, Janice M. Fullerton, Daniel L. Koller, James B. Potash, Michael McCarthy, Barbara W. Schweizer, Rebecca McKinney, Nirmala Akula, Sebastian Kliwicki, Guy A. Rouleau, N. Lackner, William Lawson, Melvin G. McInnis, Eva Z. Reininghaus, Maria Grigoroiu-Serbanescu, Pavla Stopkova, Francesc Colom, Catharina Lavebratt, Judith A. Badner, Mark A. Frye, Alexandre Dayer, Giovanni Severino, Maren Lang, John P. Rice, Per Hoffmann, William A. Scheftner, Lina Martinsson, Pamela B. Mahon, Piotr M. Czerski, Paul D. Shilling, Mazda Adli, Armin Birner, David Craig, Gustavo Turecki, Bárbara Arias, Evaristus A. Nwulia, Thomas B. Barrett, Cinnamon S. Bloss, Marion Leboyer, Chunyu Liu, Maria Del Zompo, Antonio Benabarre, Bernhard T. Baune, Fabian Streit, John I. Nurnberger, Barbara König, Anna Maaser, Wolfgang Maier, Julie Garnham, Claire Slaney, Johannes Schumacher, Cristiana Cruceanu, J. Raymond DePaulo, Martin Alda, Andrea Hofmann, Hou, Liping, Bergen, Sarah E., Akula, Nirmala, Song, Jie, Hultman, Christina M., Landén, Mikael, Adli, Mazda, Alda, Martin, Ardau, Raffaella, Arias, Barbara, Aubry, Jean-Michel, Backlund, Lena, Badner, Judith A., Barrett, Thomas B., Bauer, Michael, Baune, Bernhard T., Bellivier, Frank, Benabarre, Antonio, Bengesser, Susanne, Berrettini, Wade H., Bhattacharjee, Abesh Kumar, Biernacka, Joanna M., Birner, Armin, Bloss, Cinnamon S., Brichant-Petitjean, Clara, Bui, Elise T., Byerley, William, Cervantes, Pablo, Chillotti, Caterina, Cichon, Sven, Colom, Francesc, Coryell, William, Craig, David W., Cruceanu, Cristiana, Czerski, Piotr M., Davis, Tony, Dayer, Alexandre, Degenhardt, Franziska, Del Zompo, Maria, Depaulo, J. Raymond, Edenberg, Howard J., Étain, Bruno, Falkai, Peter, Foroud, Tatiana, Forstner, Andreas J., Frisén, Louise, Frye, Mark A., Fullerton, Janice M., Gard, Sébastien, Garnham, Julie S., Gershon, Elliot S., Goes, Fernando S., Greenwood, Tiffany A., Grigoroiu-Serbanescu, Maria, Hauser, Joanna, Heilbronner, Ur, Heilmann-Heimbach, Stefanie, Herms, Stefan, Hipolito, Maria, Hitturlingappa, Shashi, Hoffmann, Per, Hofmann, Andrea, Jamain, Stephane, Jiménez, Esther, Kahn, Jean-Pierre, Kassem, Layla, Kelsoe, John R., Kittel-Schneider, Sarah, Kliwicki, Sebastian, Koller, Daniel L., König, Barbara, Lackner, Nina, Laje, Gonzalo, Lang, Maren, Lavebratt, Catharina, Lawson, William B., Leboyer, Marion, Leckband, Susan G., Liu, Chunyu, Maaser, Anna, Mahon, Pamela B., Maier, Wolfgang, Maj, Mario, Manchia, Mirko, Martinsson, Lina, Mccarthy, Michael J., Mcelroy, Susan L., Mcinnis, Melvin G., Mckinney, Rebecca, Mitchell, Philip B., Mitjans, Marina, Mondimore, Francis M., Monteleone, Palmiero, Mühleisen, Thomas W., Nievergelt, Caroline M., Nöthen, Markus M., Novák, Toma, Nurnberger, John I., Nwulia, Evaristus A., Ösby, Urban, Pfennig, Andrea, Potash, James B., Propping, Peter, Reif, Andrea, Reininghaus, Eva, Rice, John, Rietschel, Marcella, Rouleau, Guy A., Rybakowski, Janusz K., Schalling, Martin, Scheftner, William A., Schofield, Peter R., Schork, Nicholas J., Schulze, Thomas G., Schumacher, Johanne, Schweizer, Barbaraw., Severino, Giovanni, Shekhtman, Tatyana, Shilling, Paul D., Simhandl, Christian, Slaney, Claire M., Smith, Erin N., Squassina, Alessio, Stamm, Thoma, Stopkova, Pavla, Streit, Fabian, Strohmaier, Jana, Szelinger, Szabolc, Tighe, Sarah K., Tortorella, Alfonso, Turecki, Gustavo, Vieta, Eduard, Volkert, Julia, Witt, Stephanie H., Wright, Adam, Zandi, Peter P., Zhang, Peng, Zollner, Sebastian, and Mcmahon, Francis J.

Subjects
Male, 0301 basic medicine, Bipolar Disorder, Receptor, ErbB-2, Genome-wide association study, Single-nucleotide polymorphism, Biology, 03 medical and health sciences, ddc:616.89, 0302 clinical medicine, Genetic, Molecular Biology, Genetics, Genetics (clinical), medicine, Humans, Bipolar disorder, Genetic association, Chromosomes, Human, X, Association Studies Articles, Case-control study, General Medicine, Odds ratio, Heritability, medicine.disease, 3. Good health, 030104 developmental biology, Meta-analysis, Female, 030217 neurology & neurosurgery, Genome-Wide Association Study
Abstract

Bipolar disorder (BD) is a genetically complex mental illness characterized by severe oscillations of mood and behaviour. Genome-wide association studies (GWAS) have identified several risk loci that together account for a small portion of the heritability. To identify additional risk loci, we performed a two-stage meta-analysis of >9 million genetic variants in 9,784 bipolar disorder patients and 30,471 controls, the largest GWAS of BD to date. In this study, to increase power we used ∼2,000 lithium-treated cases with a long-term diagnosis of BD from the Consortium on Lithium Genetics, excess controls, and analytic methods optimized for markers on the X-chromosome. In addition to four known loci, results revealed genome-wide significant associations at two novel loci: an intergenic region on 9p21.3 (rs12553324, P = 5.87 × 10 (-) (9); odds ratio (OR) = 1.12) and markers within ERBB2 (rs2517959, P = 4.53 × 10 (-) (9); OR = 1.13). No significant X-chromosome associations were detected and X-linked markers explained very little BD heritability. The results add to a growing list of common autosomal variants involved in BD and illustrate the power of comparing well-characterized cases to an excess of controls in GWAS.

Published
2016

16. Impact of sunlight on the age of onset of bipolar disorder

Author

Carlos López-Jaramillo, Ana González-Pinto, Frank Bellivier, Claire O'Donovan, Sebastian Kliwicki, Christian Simhandl, Carla Torrent, Barbara König, Martin Alda, Mónica Martínez-Cengotitabengoa, Raffaella Ardau, Letizia Bossini, Thomas Bjella, Mark A. Frye, Andreas Reif, Eduard Vieta, Chantal Henry, Natalie L. Rasgon, Rodrigo A. Munoz, Ingrid Melle, Gunnar Morken, Flávio Kapczinski, Wendy K. Marsh, Beny Lafer, Danilo Quiroz, Maria Del Zompo, Michael Bauer, Mark Zetin, Michael Berk, Andrea Fagiolini, Janusz K. Rybakowski, Ole A. Andreassen, Seetal Dodd, Peter C. Whybrow, Andrea Pfennig, Tasha Glenn, Maurício Kunz, Mirko Manchia, Kemal Sagduyu, and Fabiano G. Nery

Subjects
Sunlight, Insolation, Genetic heterogeneity, medicine.disease, 3. Good health, 030227 psychiatry, Developmental psychology, 03 medical and health sciences, Psychiatry and Mental health, 0302 clinical medicine, medicine, Circadian rhythm, Bipolar disorder, Family history, Age of onset, Socioeconomic status, 030217 neurology & neurosurgery, Biological Psychiatry, Demography
Abstract

Bipolar disorder may emerge during several decades of life. Studies from many countries have reported three peaks in the distribution of the age of onset, occurring at about ages 17, 26, and over 40 (1–5). Differences in the distribution of the age of onset were also reported among countries (6), although only limited data are available from some regions of the world. Patients living in North America generally have a younger age of onset than those living in European countries (6–8). In many studies conducted in the USA, about 60% of patients experience the onset of bipolar disorder before the age of 19 (6, 9–12), as compared to a third or less for many studies in European countries (1, 5, 6, 13–16). Diverse factors may contribute to this variation in the age of onset. There is agreement among researchers that both a patient’s genetic makeup and methodological issues in defining onset contribute to the reported differences, and that the variability in the age of onset reflects the genetic heterogeneity underlying bipolar disorder (1–3, 17). A positive family history is one of the strongest predictors of early onset (18). However, in addition to the genetic component, both the broad variability in the age of onset, and the onset peaks occurring after puberty (19) suggest that non-genetic factors may have considerable influence (20). There is limited understanding of how non-genetic factors, such as socioeconomic status and the physical environment, may impact the expression of bipolar disorder (21). In a recent study, a linear association was detected between the age of onset of schizophrenia and latitude, with a much younger onset occurring in individuals living closer to the equator (22). Latitude is often used as a proxy measure of sunlight, such as in studies of seasonal and geographical variation in affective disorders and suicide (23–28). However, more direct measures of the amount of electromagnetic energy striking the surface of the earth are now available, such as solar insolation (29). Sunlight is the primary synchronizer of circadian rhythmicity in most animals, including humans (30), and disruptions in circadian function may contribute to the pathophysiology of bipolar disorder (31). The purpose of this study was to investigate if the age of onset of bipolar I (BP-I) disorder was associated with sunlight at the location of onset, as measured by solar insolation.

Published
2012

17. Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy

Author

Agnieszka Permoda-Osip, Aleksandra Szczepankiewicz, Sebastian Kliwicki, Aleksandra Suwalska, Piotr M. Czerski, Janusz K. Rybakowski, Joanna Hauser, Anna Leszczynska-Rodziewicz, Monika Dmitrzak-Weglarz, and Maria Skibinska

Subjects
Adult, Male, Candidate gene, Bipolar Disorder, Lithium (medication), 5-HT2A receptor, Drug Resistance, Pharmacology, Catechol O-Methyltransferase, Proto-Oncogene Proteins c-fyn, Bioinformatics, Polymorphism, Single Nucleotide, Pathogenesis, Lithium Carbonate, Antimanic Agents, mental disorders, Secondary Prevention, medicine, Humans, Pharmacology (medical), Bipolar disorder, Genetic Association Studies, Aged, Serotonin Plasma Membrane Transport Proteins, biology, Mechanism (biology), Brain-Derived Neurotrophic Factor, Receptors, Dopamine D1, Middle Aged, medicine.disease, Diagnostic and Statistical Manual of Mental Disorders, Psychiatry and Mental health, Amino Acid Substitution, biology.protein, Female, GRIN2B, Poland, Psychology, Pharmacogenetics, medicine.drug
Abstract

A number of candidate genes for lithium prophylactic efficacy have been proposed, some of them being also associated with a predisposition to bipolar illness. The aim of the present study was to investigate a possible association between polymorphisms of 14 common genes with the quality of prophylactic lithium response in patients with bipolar mood disorder, in relation to the putative role of these genes in the pathogenesis of this disorder. Some association with lithium prophylactic efficacy was found for the polymorphisms of 5HTT, DRD1, COMT, BDNF and FYN genes, but not for 5HT2A, 5HT2C, DRD2, DRD3, DRD4, GSK-3, NTRK2, GRIN2B and MMP-9. Possible aspects of these genes with regard to the mechanism of lithium activity and pathogenesis of bipolar mood disorder are discussed.

Published
2011

18. Influence of birth cohort on age of onset cluster analysis in bipolar I disorder

Author

Erkki Isometsä, Christian Simhandl, Glenda MacQueen, Rikke Krogh, Yamima Osher, Hirohiko Harima, Kirsi Suominen, Scott Monteith, Peter C. Whybrow, Hiromi Tagata, Mark A. Frye, Ana González-Pinto, Chantal Henry, M. Del Zompo, Rajkumar Ramesar, Seetal Dodd, Claire O'Donovan, Ole A. Andreassen, Raffaella Ardau, Elias Angelopoulos, Biju Viswanath, Sebastian Kliwicki, Yuly Bersudsky, Natalie L. Rasgon, Beny Lafer, Emanuel Severus, Angela M. Scippa, Michael Bauer, Eric Yat Wo Cheung, Erik Roj Larsen, Jade Garneau-Fournier, Danilo Quiroz, Dan J. Stein, Jörn Conell, Michael Berk, Andrea Fagiolini, Janusz K. Rybakowski, Martin Alda, Ute Lewitzka, Christopher Baethge, Letizia Bossini, Mónica Martínez-Cengotitabengoa, Flávio Kapczinski, Frank Bellivier, Sergio Strejilevich, Gunnar Morken, Carla Torrent, Mihir J. Wanchoo, Eduard Vieta, Mark Zetin, Philipp Ritter, Maurício Kunz, Andreas Reif, Ingrid Melle, Yoshitaka Tatebayashi, Apostolos Iacovides, A. Hatim Sulaiman, Wendy K. Marsh, Konstantinos N. Fountoulakis, Bruno Etain, Tasha Glenn, Rita Bauer, Carlos López-Jaramillo, Andrea Pfennig, Robert H. Belmaker, Mirko Manchia, Stefanie Hassel, Kemal Sagduyu, Fabiano G. Nery, Thomas Bjella, Rodrigo A. Munoz, and Barbara König

Subjects
Adult, Male, Pediatrics, medicine.medical_specialty, Bipolar Disorder, Bipolar I disorder, Databases, Factual, Bipolar disorder, International Cooperation, Age of onset, Global Health, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Cluster analysis, GRUPOS CONTROLE, medicine, Cluster Analysis, Humans, Age of Onset, Family history, Generalized estimating equation, Aged, First episode, Mood Disorders, business.industry, Retrospective cohort study, Middle Aged, medicine.disease, 030227 psychiatry, Psychiatry and Mental health, Female, business, 030217 neurology & neurosurgery, Birth cohort, Cohort study
Abstract

Purpose:Two common approaches to identify subgroups of patients with bipolar disorder are clustering methodology (mixture analysis) based on the age of onset, and a birth cohort analysis. This study investigates if a birth cohort effect will influence the results of clustering on the age of onset, using a large, international database.Methods:The database includes 4037 patients with a diagnosis of bipolar I disorder, previously collected at 36 collection sites in 23 countries. Generalized estimating equations (GEE) were used to adjust the data for country median age, and in some models, birth cohort. Model-based clustering (mixture analysis) was then performed on the age of onset data using the residuals. Clinical variables in subgroups were compared.Results:There was a strong birth cohort effect. Without adjusting for the birth cohort, three subgroups were found by clustering. After adjusting for the birth cohort or when considering only those born after 1959, two subgroups were found. With results of either two or three subgroups, the youngest subgroup was more likely to have a family history of mood disorders and a first episode with depressed polarity. However, without adjusting for birth cohort (three subgroups), family history and polarity of the first episode could not be distinguished between the middle and oldest subgroups.Conclusion:These results using international data confirm prior findings using single country data, that there are subgroups of bipolar I disorder based on the age of onset, and that there is a birth cohort effect. Including the birth cohort adjustment altered the number and characteristics of subgroups detected when clustering by age of onset. Further investigation is needed to determine if combining both approaches will identify subgroups that are more useful for research.

Published
2015

19. Influence of light exposure during early life on the age of onset of bipolar disorder

Author

Elias Angelopoulos, Peter C. Whybrow, Ângela Miranda-Scippa, Janusz K. Rybakowski, Jörn Conell, Flávio Kapczinski, Christian Simhandl, Ole A. Andreassen, Michael Bauer, Biju Viswanath, Jade Garneau-Fournier, Michael Berk, Andrea Fagiolini, Danilo Quiroz, Erkki Isometsä, Hiromi Tagata, Mark A. Frye, Maria Del Zompo, Scott Monteith, Chantal Henry, Bruno Etain, Ana González-Pinto, Yoshitaka Tatebayashi, Christopher Baethge, Erik Roj Larsen, Fabiano G. Nery, Rikke Krogh, Kostas N. Fountoulakis, Carlos López-Jaramillo, Frank Bellivier, Apostolos Iacovides, Sebastian Kliwicki, Ute Lewitzka, Raj Ramesar, Andrea Pfennig, Emanuel Severus, Eric Yat Wo Cheung, Kemal Sagduyu, Beny Lafer, Eduard Vieta, Philipp Ritter, Yamima Osher, Ingrid Melle, Sergio Strejilevich, Andreas Reif, Kirsi Suominen, Mirko Manchia, Yuly Bersudsky, Natalie L. Rasgon, Stefanie Hassel, Bernhard T. Baune, Seetal Dodd, Wendy K. Marsh, Letizia Bossini, Maurício Kunz, Gunnar Morken, Mihir J. Wanchoo, Glenda MacQueen, Raffaella Ardau, Hirohiko Harima, Carla Torrent, Robert H. Belmaker, Mark Zetin, Tasha Glenn, Rita Bauer, Thomas Bjella, Rodrigo A. Munoz, Barbara König, Ahmad Hatim Sulaiman, Dan J. Stein, Martin Alda, Mónica Martínez-Cengotitabengoa, John F. Gottlieb, and Claire O'Donovan

Subjects
Gerontology, Adult, Male, Bipolar I disorder, Bipolar Disorder, Databases, Factual, Climate, International Cooperation, Poison control, Cohort Studies, Hours of daylight, Arts and Humanities (miscellaneous), Insolation, medicine, Humans, Daylight, Bipolar disorder, Circadian rhythm, Age of Onset, Biological Psychiatry, Aged, Sunlight, Aged, 80 and over, business.industry, Middle Aged, Age of onset, Psychiatry and Mental Health, medicine.disease, Psychiatry and Mental health, Mood disorders, Female, Seasons, business, Demography
Abstract

BACKGROUND: Environmental conditions early in life may imprint the circadian system and influence response to environmental signals later in life. We previously determined that a large springtime increase in solar insolation at the onset location was associated with a younger age of onset of bipolar disorder, especially with a family history of mood disorders. This study investigated whether the hours of daylight at the birth location affected this association.METHODS: Data collected previously at 36 collection sites from 23 countries were available for 3896 patients with bipolar I disorder, born between latitudes of 1.4 N and 70.7 N, and 1.2 S and 41.3 S. Hours of daylight variables for the birth location were added to a base model to assess the relation between the age of onset and solar insolation.RESULTS: More hours of daylight at the birth location during early life was associated with an older age of onset, suggesting reduced vulnerability to the future circadian challenge of the springtime increase in solar insolation at the onset location. Addition of the minimum of the average monthly hours of daylight during the first 3 months of life improved the base model, with a significant positive relationship to age of onset. Coefficients for all other variables remained stable, significant and consistent with the base model.CONCLUSIONS: Light exposure during early life may have important consequences for those who are susceptible to bipolar disorder, especially at latitudes with little natural light in winter. This study indirectly supports the concept that early life exposure to light may affect the long term adaptability to respond to a circadian challenge later in life.

Published
2014

20. TEMPS-A and long-term lithium response: Positive correlation with hyperthymic temperament

Author

Janusz K. Rybakowski, Hagop H. Akiskal, Kareen K. Akiskal, Daria Dembinska, and Sebastian Kliwicki

Subjects
Adult, Male, Hyperthymic temperament, medicine.medical_specialty, Bipolar Disorder, Time Factors, Personality Inventory, Lithium (medication), media_common.quotation_subject, Anxiety, Lithium, Five Temperaments, Treatment of bipolar disorder, chemistry.chemical_compound, Antimanic Agents, medicine, Humans, Bipolar disorder, Temperament, Psychiatry, Aged, media_common, Aged, 80 and over, Depression, Lithium carbonate, Middle Aged, medicine.disease, Cyclothymic Disorder, Irritable Mood, Psychiatry and Mental health, Clinical Psychology, Treatment Outcome, chemistry, Female, medicine.symptom, Psychology, medicine.drug, Clinical psychology
Abstract

Background Lithium is still regarded as a cornerstone for the long-term treatment of bipolar disorder. The best response to lithium is associated with clinical features of episodic clinical course, complete remission, bipolar family history and low psychiatric comorbidity. However, a specific personality profile for the best lithium response was not estimated so far. Such a possibility occurred with an advent of temperament scale for bipolar disorder and of an ability to quantitatively assess lithium prophylactic response. Methods The study was performed on 71 patients with bipolar mood disorder (21 males, 50 females), aged 31–82 (59±12) years, which have been treated with lithium carbonate for at least 5 years (5–37 years, mean 15 years). In all patients, the assessment of five temperaments of TEMPS-A scale (depressive, cyclothymic, hyperthymic, irritable and anxious) was done, and correlated with the quality of lithium prophylaxis according to Alda scale. Results The mean scores for five temperaments of TEMPS-A were not significantly different in male and female patients. The response to lithium correlated significantly positively with hyperthymic temperament score (r=0.31, p=0.009), and negatively with anxiety (r=−0.27, p=0.022), cyclothymic (r=−0.26, p=0.032), and depressive (r=−0.23, p=0.052) temperaments scores. Limitations Relatively small number of patients. Conclusions The main finding of the study is an association of lithium response with hyperthymic temperament. This positive correlation as well as other negative correlations between lithium response and TEMPS-A temperaments are discussed in view of clinical and genetic findings in bipolar patients.

Published
2013

21. Relationship between sunlight and the age of onset of bipolar disorder:an international multisite study

Author

Ahmad Hatim Sulaiman, Dan J. Stein, Martin Alda, Mónica Martínez-Cengotitabengoa, Yoshitaka Tatebayashi, Thomas Bjella, Mihir J. Wanchoo, Claire O'Donovan, Biju Viswanath, Michael Bauer, Jade Garneau-Fournier, Emanuel Severus, Christian Simhandl, Bruno Etain, Erkki Isometsä, Hiromi Tagata, Michael Berk, Mark A. Frye, Andrea Pfennig, Eric Yat Wo Cheung, Carla Torrent, Andrea Fagiolini, Rodrigo A. Munoz, Carlos López-Jaramillo, Sergio Strejilevich, Eduard Vieta, Kemal Sagduyu, Rikke Krogh, Chantal Henry, Beny Lafer, Raffaella Ardau, Elias Angelopoulos, Ângela Miranda Scippa, Ingrid Melle, Janusz K. Rybakowski, Yuly Bersudsky, Natalie L. Rasgon, Christopher Baethge, Maria Del Zompo, Flávio Kapczinski, Jörn Conell, Glenda MacQueen, Danilo Quiroz, Kirsi Suominen, Hirohiko Harima, Erik Roj Larsen, Mirko Manchia, Andreas Reif, Wendy K. Marsh, Stefanie Hassel, Kostas N. Fountoulakis, Mark Zetin, Yamima Osher, Tasha Glenn, Frank Bellivier, Scott Monteith, Rita Bauer, Fabiano G. Nery, Apostolos Iacovides, Ana González-Pinto, Ute Lewitzka, Raj Ramesar, Philipp Ritter, Maurício Kunz, Sebastian Kliwicki, Robert H. Belmaker, Barbara König, Ole A. Andreassen, Letizia Bossini, Gunnar Morken, Peter C. Whybrow, and Seetal Dodd

Subjects
Adult, Male, Gerontology, Bipolar I disorder, Adolescent, Bipolar disorder, Climate, Age of onset, Global Health, 03 medical and health sciences, 0302 clinical medicine, Insolation, medicine, Humans, Family history, Retrospective Studies, First episode, Sunlight, Depressive Disorder, Depression, Mood Disorders, Middle Aged, medicine.disease, 030227 psychiatry, Psychiatry and Mental health, Clinical Psychology, Geography, Mood disorders, 13. Climate action, Female, Seasons, medicine.symptom, Mania, 030217 neurology & neurosurgery, Demography
Abstract

BACKGROUND: The onset of bipolar disorder is influenced by the interaction of genetic and environmental factors. We previously found that a large increase in sunlight in springtime was associated with a lower age of onset. This study extends this analysis with more collection sites at diverse locations, and includes family history and polarity of first episode.METHODS: Data from 4037 patients with bipolar I disorder were collected at 36 collection sites in 23 countries at latitudes spanning 3.2 north (N) to 63.4 N and 38.2 south (S) of the equator. The age of onset of the first episode, onset location, family history of mood disorders, and polarity of first episode were obtained retrospectively, from patient records and/or direct interview. Solar insolation data were obtained for the onset locations.RESULTS: There was a large, significant inverse relationship between maximum monthly increase in solar insolation and age of onset, controlling for the country median age and the birth cohort. The effect was reduced by half if there was no family history. The maximum monthly increase in solar insolation occurred in springtime. The effect was one-third smaller for initial episodes of mania than depression. The largest maximum monthly increase in solar insolation occurred in northern latitudes such as Oslo, Norway, and warm and dry areas such as Los Angeles, California.LIMITATIONS: Recall bias for onset and family history data.CONCLUSIONS: A large springtime increase in sunlight may have an important influence on the onset of bipolar disorder, especially in those with a family history of mood disorders.

Published
2014

22. [Factors connected with efficacy of single ketamine infusion in bipolar depression]

Author

Agnieszka Permoda-Osip, Alicja Bartkowska-Sniatkowska, Maria Skibinska, Janusz K. Rybakowski, Maria Chłopocka-Woźniak, and Sebastian Kliwicki

Subjects
Adult, Male, Bipolar Disorder, Homocysteine, Severity of Illness Index, chemistry.chemical_compound, Young Adult, Severity of illness, medicine, Humans, Ketamine, Vitamin B12, Young adult, Infusions, Intravenous, Depression (differential diagnoses), Aged, Psychiatric Status Rating Scales, Dose-Response Relationship, Drug, business.industry, General Medicine, Middle Aged, Antidepressive Agents, Discontinuation, Psychiatry and Mental health, Treatment Outcome, chemistry, Anesthesia, Antidepressant, Female, business, medicine.drug
Abstract

CelCelem pracy była ocena skuteczności jednorazowego wlewu ketaminy oraz czynników klinicznych i biochemicznych ją warunkujących, u pacjentów z depresją w przebiegu choroby afektywnej dwubiegunowej (CHAD), u których stosowanie leków przeciwdepresyjnych nie przyniosło poprawy.MetodaBadano 42 pacjentów (32 kobiet, 10 mężczyzn) w wieku 22-67 lat z depresją w przebiegu CHAD otrzymujących ≥1 lek normotymiczny pierwszej lub/i drugiej generacji. Po odstawieniu leków przeciwdepresyjnych (≥7 dni), wykonywano wlew ketaminy (0.5mg/kg masy ciała). Ocenę depresji w 17-punktowej Skali Depresji Hamiltona przeprowadzano przed oraz po 1, 3, 7 i 14 dniach po podaniu ketaminy. Kryterium poprawy klinicznej stanowiło zmniejszenie sie o ≥50% punktacji w skali Hamiltona po 7 dniach. W podgrupie 20 pacjentów, przed podaniem ketaminy wykonano badania stężenia homocysteiny, witaminy B12, kwasu foliowego, neurotrofin oraz białek reakcji zapalnej.WynikiW całej grupie nasilenie depresji w skali Hamiltona istotnie zmniejszyło się po 24 godzinach od podania ketaminy z 22,6+5,1 do 15,6+7,4 punktów. Po 7 dniach wynosiło 13±7 i po 14 dniach 11,8±7,8 punktów. Osoby z poprawą kliniczną (n=22) miały istotnie częstsze występowanie uzależnienia od alkoholu oraz alkoholizmu w rodzinie. Badania biochemiczne w podgrupie 20 pacjentów wykazały u osób z poprawą kliniczną (n=10) wyższe stężenia witaminy B12 oraz receptora 1 czynnika wzrostu śródbłonka naczyniowego w surowicy przed podaniem ketaminy. Wlew ketaminy był dobrze tolerowany.WnioskiWyniki potwierdzają szybki przeciwdepresyjny efekt infuzji ketaminy utrzymujący się przez 2 tygodnie, u znacznej części pacjentów z depresją w przebiegu CHAD oraz dobrą tolerancję kliniczną takiej procedury. Wykazano również niektóre czynniki kliniczne i biochemiczne związane z korzystnym działaniem ketaminy.

Published
2014

23. Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report

Author

J. Raymond DePaulo, Martin Alda, Alfonso Tortorella, Susan G. Leckband, Jean-Michel Aubry, James B. Potash, Clara Brichant-Petitjean, Layla Kassem, Joanna Hauser, Tomas Novak, David Zilles, Claire O'Donovan, Rebecca Hoban, Sarah Kittel-Schneider, Claire Slaney, Lena Backlund, Peter Falkai, Andrew T. A. Cheng, John R. Kelsoe, Andrea Pfennig, Janice M. Fullerton, Marcella Rietschel, Caterina Chillotti, Stéphane Jamain, Elise Bui, Po-Hsiu Kuo, Alessio Squassina, Claudio E. M. Banzato, Joanna M. Biernacka, Lisa R. Seymour, Naomi R. Wray, Ichiro Kusumi, Thomas Stamm, Fernando S. Goes, Audrey Nallet, Sarah K. Tighe, Giovanni Severino, Jean-Pierre Kahn, Maria Neuner, Nirmala Akula, Norio Ozaki, Francis J. McMahon, Frank Bellivier, Andreas Reif, Ryota Hashimoto, Barbara W. Schweizer, Palmiero Monteleone, Florian Seemüller, Urs Heilbronner, Sevilla D. Detera-Wadleigh, Pavla Stopkova, Martin Schalling, Julie Garnham, Sébastien Gard, Mark A. Frye, Eva Z. Reininghaus, Lina Martinsson, Urban Ösby, Maria Grigoroiu-Serbanescu, Sara Richardson, Tadafumi Kato, Marion Leboyer, Catharina Lavebratt, Piotr M. Czerski, Scott R. Clark, Daniela Reich-Erkelenz, Sebastian Kliwicki, Guy A. Rouleau, Oliver Gruber, Gonzalo Laje, Adam Wright, Gustavo Turecki, Roy H. Perlis, Takuya Masui, Mirko Manchia, Bernhard T. Baune, Mazda Adli, Michael Bauer, Sven Cichon, Frank Mondimore, Bruno Etain, Philip B. Mitchell, Thomas G. Schulze, Peter P. Zandi, Raffaella Ardau, Peter R. Schofield, Susanne Bengesser, Liping Hou, Janusz K. Rybakowski, Mario Maj, Clarissa de Rosalmeida Dantas, Louise Frisén, O. Schubert, Carlos Jaramillo, Maria Del Zompo, Paul Grof, Cynthia V. Calkin, Jo Steele, Jordan W. Smoller, Alain Malafosse, Manchia, M, Adli, M, Akula, N, Ardau, R, Aubry, Jm, Backlund, L, Banzato, Ce, Baune, Bt, Bellivier, F, Bengesser, S, Biernacka, Jm, Brichant Petitjean, C, Bui, E, Calkin, Cv, Cheng, At, Chillotti, C, Cichon, S, Clark, S, Czerski, Pm, Dantas, C, Zompo, Md, Depaulo, Jr, Detera Wadleigh, Sd, Etain, B, Falkai, P, Frisén, L, Frye, Ma, Fullerton, J, Gard, S, Garnham, J, Goes, F, Grof, P, Gruber, O, Hashimoto, R, Hauser, J, Heilbronner, U, Hoban, R, Hou, L, Jamain, S, Kahn, Jp, Kassem, L, Kato, T, Kelsoe, Jr, Kittel Schneider, S, Kliwicki, S, Kuo, Ph, Kusumi, I, Laje, G, Lavebratt, C, Leboyer, M, Leckband, Sg, López Jaramillo, Ca, Maj, Mario, Malafosse, A, Martinsson, L, Masui, T, Mitchell, Pb, Mondimore, F, Monteleone, P, Nallet, A, Neuner, M, Novák, T, O'Donovan, C, Osby, U, Ozaki, N, Perlis, Rh, Pfennig, A, Potash, Jb, Reich Erkelenz, D, Reif, A, Reininghaus, E, Richardson, S, Rouleau, Ga, Rybakowski, Jk, Schalling, M, Schofield, Pr, Schubert, Ok, Schweizer, B, Seemüller, F, Grigoroiu Serbanescu, M, Severino, G, Seymour, Lr, Slaney, C, Smoller, Jw, Squassina, A, Stamm, T, Steele, J, Stopkova, P, Tighe, Sk, Tortorella, Alfonso Antonio Vincenzo, Turecki, G, Wray, Nr, Wright, A, Zandi, Pp, Zilles, D, Bauer, M, Rietschel, M, Mcmahon, Fj, Schulze, Tg, Alda, M., Department of Psychiatry, Dalhousie University [Halifax], Department of Psychiatry and Psychotherapy, Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], Human Genetics Branch, National Institutes of Health [Bethesda] (NIH)-National Institute of Mental Health (NIMH), Unit of Clinical Pharmacology, University-Hospital of Cagliari, Department of Mental Health and Psychiatry, University Hospital of Geneva, Trinity College Dublin-St. James's Hospital, University of Campinas [Campinas] (UNICAMP), University of Adelaide, Pôle de Psychiatrie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Medical University Graz, Mayo Clinic, Division of Epidemiology and Genetics, Academia Sinica-Institute of Biomedical Sciences (ICB/USP), Universidade de São Paulo (USP)-Universidade de São Paulo (USP), Department of Genomics, Life and Brain Center, University of Bonn, Psychiatric Genetic Unit, Poznan University of Medical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-IFR10, University of Homburg, Genetics of Mental Illness and Brain Function, Neuroscience Research Australia, Service de psychiatrie adulte, Université Bordeaux Segalen - Bordeaux 2-Hôpital Charles Perrens-Centre Expert Trouble Bipolaire, Mood Disorders Center of Ottawa (MDCO), University of Ottawa [Ottawa], University of Toronto, Georg-August-University [Göttingen], Osaka University Graduate School of Medicine, University of California [San Diego] (UC San Diego), University of California-University of California, Service de Psychiatrie et Psychologie Clinique, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Hôpital Jeanne-d'Arc, Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Center for Brain Science [Wako] (RIKEN CBS), RIKEN - Institute of Physical and Chemical Research [Japon] (RIKEN)-RIKEN - Institute of Physical and Chemical Research [Japon] (RIKEN), Mental Health Sciences Unit, University College of London [London] (UCL), Department of Adult Psychiatry, Institute of Epidemiology and Preventive Medicine, National Taiwan University [Taiwan] (NTU), Hokkaido University Graduate School of Medicine, Molecular Medicine and Surgery department, Karolinska Institutet [Stockholm], Center for Molecular Medicine, Karolinska University Hospital [Stockholm], Department of Pharmacy, Veterans Affairs San Diego Healthcare System, Skaggs School of Pharmacy and Pharmaceutical Sciences [San Diego], University of Antioquia, University of Napoli, School of Psychiatry, University of New South Wales [Sydney] (UNSW)-Black Dog Institute, Prague Psychiatric Center, University of Prague, Fujita Health University School of Medicine, Nagoya University Graduate School of Medicine, Harvard Medical School [Boston] (HMS)-Massachusetts General Hospital [Boston], Technische Universität Dresden = Dresden University of Technology (TU Dresden), University of Iowa [Iowa City], Center of Excellence in Neuroscience, CHU de Montréal, Department of Medicine, Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CR CHUM), Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal (UdeM)-Université de Montréal (UdeM)-Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal (UdeM)-Université de Montréal (UdeM), Biometric Psychiatric Genetics Research Unit, Alexandru Obregia Psychiatric Hospital, McGill Group for Suicide Studies, Douglas Mental Health University Institute, Queensland Brain Institute, University of Queensland [Brisbane], Department of Mental Health, Johns Hopkins Bloomberg School of Public Health [Baltimore], Johns Hopkins University (JHU)-Johns Hopkins University (JHU), Department of Genetic Epidemiology in Psychiatry [Mannhein], Universität Heidelberg [Heidelberg]-Central Institute of Mental Health Mannheim, The work on assessment of lithium response has been supported by a grant from Canadian Institutes of Health Research #64410 to MA. MG-S was supported by Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI), Bucharest, Romania (grant no. 89/2012). JMA and AN were supported by a grant from the Swiss National Foundation (#32003B_125469/1 to JM Aubry). ConLiGen is in part supported by funds from the Intramural Research Program of the National Institute of Mental Health (NIMH) at the National Institutes of Health (NIH), Department of Health and Human Services, United States Government, Aubry, Jean-Michel, Universidade Estadual de Campinas = University of Campinas (UNICAMP), Universidade de São Paulo = University of São Paulo (USP)-Universidade de São Paulo = University of São Paulo (USP), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Georg-August-University = Georg-August-Universität Göttingen, University of California (UC)-University of California (UC), Guellaen, Georges, Université Bordeaux Segalen - Bordeaux 2-Centre hospitalier Charles Perrens [Bordeaux]-Centre Expert Trouble Bipolaire, and Ikeda, Kazutaka

Subjects
Male, Bipolar Disorder, Lithium (medication), Psychometrics, Psychopharmacology, Epidemiology, International Cooperation, lcsh:Medicine, Lithium, Maintenance Treatment, ConLiGen, ddc:616.89, 0302 clinical medicine, Antimanic Agents, Psychology, lcsh:Science, Reliability (statistics), Psychiatry, Genetics, 0303 health sciences, Multidisciplinary, ASSOCIATION, Genomics, Pharmacoepidemiology, 3. Good health, Mental Health, Phenotype, Treatment Outcome, MAPPING SUSCEPTIBILITY GENES, Behavioral Pharmacology, RELIABILITY, Lithium Compounds, Medicine, Female, Research Article, medicine.drug, Drugs and Devices, MAPPING SUSCEPTIBILITY GENES, PROPHYLACTIC LITHIUM, OBSERVER AGREEMENT, MOOD DISORDERS, ONSET, ASSOCIATION, RELIABILITY, MORTALITY, ILLNESS, AGE, ILLNESS, PROPHYLACTIC LITHIUM, 03 medical and health sciences, AGE, Neuropharmacology, Genomic Medicine, [SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology, Genome-Wide Association Studies, medicine, Humans, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, Bipolar disorder, ddc:610, Biology, 030304 developmental biology, Mood Disorders, business.industry, MORTALITY, lcsh:R, Computational Biology, Reproducibility of Results, Models, Theoretical, medicine.disease, OBSERVER AGREEMENT, Mood disorders, Pharmacogenetics, Therapies, ONSET, lcsh:Q, Pharmacogenomics, business, 030217 neurology & neurosurgery, Kappa
Abstract

Objective: The assessment of response to lithium maintenance treatment in bipolar disorder (BD) is complicated by variable length of treatment, unpredictable clinical course, and often inconsistent compliance. Prospective and retrospective methods of assessment of lithium response have been proposed in the literature. In this study we report the key phenotypic measures of the "Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder" scale currently used in the Consortium on Lithium Genetics (ConLiGen) study. Materials and Methods: Twenty-nine ConLiGen sites took part in a two-stage case-vignette rating procedure to examine inter-rater agreement [Kappa (\(\kappa\))] and reliability [intra-class correlation coefficient (ICC)] of lithium response. Annotated first-round vignettes and rating guidelines were circulated to expert research clinicians for training purposes between the two stages. Further, we analyzed the distributional properties of the treatment response scores available for 1,308 patients using mixture modeling. Results: Substantial and moderate agreement was shown across sites in the first and second sets of vignettes (\(\kappa\) = 0.66 and \(\kappa\) = 0.54, respectively), without significant improvement from training. However, definition of response using the A score as a quantitative trait and selecting cases with B criteria of 4 or less showed an improvement between the two stages (\(ICC_1 = 0.71\) and \(ICC_2 = 0.75\), respectively). Mixture modeling of score distribution indicated three subpopulations (full responders, partial responders, non responders). Conclusions: We identified two definitions of lithium response, one dichotomous and the other continuous, with moderate to substantial inter-rater agreement and reliability. Accurate phenotypic measurement of lithium response is crucial for the ongoing ConLiGen pharmacogenomic study.

Published
2013

24. The International Consortium on Lithium Genetics (ConLiGen): An Initiative by the NIMH and IGSLI to Study the Genetic Basis of Response to Lithium Treatment

Author

Thomas G. Schulze, L. Trevor Young, Layla Kassem, Paola Piccardi, Andrea Pfennig, Caterina Chillotti, Raffaella Ardau, Paul Grof, Oliver Gruber, Michael Bauer, Ichiro Kusumi, Johannes Schumacher, Sven Cichon, Nakao Iwata, Mazda Adli, Janusz K. Rybakowski, Glenda MacQueen, Maria Del Zompo, Elise T. Bui, Susan G. Leckband, Giovanni Severino, Jordan W. Smoller, Sarah Kittel-Schneider, Sevilla D. Detera-Wadleigh, Gonzalo Laje, Norio Ozaki, Piotr M. Czerski, Andreas Reif, Takeo Yoshikawa, Ryota Hashimoto, Gustavo Turecki, Mirko Manchia, Martin Alda, Nirmala Akula, Sebastian Kliwicki, Guy A. Rouleau, Joanna Hauser, John R. Kelsoe, Johanna Sasse, Alessio Squassina, Francis J. McMahon, Rebecca Hoban, Roy H. Perlis, Takuya Masui, Sara Richardson, and Tadafumi Kato

Subjects
Paper, medicine.medical_specialty, Bipolar Disorder, Lithium (medication), medicine.drug_class, International Cooperation, Schizoaffective disorder, Antimanic Agents, 03 medical and health sciences, 0302 clinical medicine, ddc:150, medicine, Humans, Manic-depressive illness, Mood stabilizer, Antidepressants, Suicidal behavior, Genome-wide association study, Neurogenesis, Neuroplasticity, ddc:610, Bipolar disorder, Psychiatry, Biological Psychiatry, National Institute of Mental Health (U.S.), Genetics, medicine.disease, United States, 030227 psychiatry, 3. Good health, Psychiatry and Mental health, Neuropsychology and Physiological Psychology, Mood, Phenotype, Pharmacogenetics, Lithium Compounds, Manic-depressive illness, Schizoaffective disorder, Mood stabilizer, Antidepressants, Suicidal behaviour, Genome-wide association study, Neurogenesis, Neuroplasticity, Antidepressant, Anxiety, medicine.symptom, Psychology, manisch-depressive Erkrankung, bipolare Störung, Schizoaffektive Störung, Stimmungsstabilisierer, Phasenprophylaktikum, Antidepressiva, Suizidalität, genomweite Assoziationsstudie, Neurogenese, Neuronale Plastizität, 030217 neurology & neurosurgery, Clinical psychology, medicine.drug
Abstract

For more than half a decade, lithium has been successfully used to treat bipolar disorder. Worldwide, it is considered the first-line mood stabilizer. Apart from its proven antimanic and prophylactic effects, considerable evidence also suggests an antisuicidal effect in affective disorders. Lithium is also effectively used to augment antidepressant drugs in the treatment of refractory major depressive episodes and prevent relapses in recurrent unipolar depression. In contrast to many psychiatric drugs, lithium has outlasted various pharmacotherapeutic ‘fashions’, and remains an indispensable element in contemporary psychopharmacology. Nevertheless, data from pharmacogenetic studies of lithium are comparatively sparse, and these studies are generally characterized by small sample sizes and varying definitions of response. Here, we present an international effort to elucidate the genetic underpinnings of lithium response in bipolar disorder. Following an initiative by the International Group for the Study of Lithium-Treated Patients (www.IGSLI.org) and the Unit on the Genetic Basis of Mood and Anxiety Disorders at the National Institute of Mental Health,lithium researchers from around the world have formed the Consortium on Lithium Genetics (www.ConLiGen.org) to establish the largest sample to date for genome-wide studies of lithium response in bipolar disorder, currently comprising more than 1,200 patients characterized for response to lithium treatment. A stringent phenotype definition of response is one of the hallmarks of this collaboration. ConLiGen invites all lithium researchers to join its efforts. Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.

Published
2010

Catalog

Books, media, physical & digital resources
See catalog results